Loading...
Header Logo
Keywords
Last Name
Institution

GEORGE A CALIN

TitleProfessor
InstitutionMD Anderson
DepartmentExperimental Therapeutics
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Li Z, Wong KY, Calin GA, Chng WJ, Chan GC, Chim CS. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact. Clin Epigenetics. 2019 May 07; 11(1):71. PMID: 31064412.
      View in: PubMed
    2. Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, Welsh J, Calin GA. Role of miRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer. 2019 04; 58(4):244-253. PMID: 30578699.
      View in: PubMed
    3. Pardini B, Calin GA. MicroRNAs and Long Non-Coding RNAs and Their Hormone-Like Activities in Cancer. Cancers (Basel). 2019 Mar 17; 11(3). PMID: 30884898.
      View in: PubMed
    4. Farooqi AA, Fuentes-Mattei E, Fayyaz S, Raj P, Goblirsch M, Poltronieri P, Calin GA. Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer. Semin Cancer Biol. 2019 Feb 08. PMID: 30742906.
      View in: PubMed
    5. Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, Stanzer S, Rinnerthaler G, Stoeger H, Bauernhofer T, Haybaeck J, Hoefler G, Jahn SW, Parrella P, Calin GA, Pichler M. MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors. Breast Cancer Res. 2019 02 01; 21(1):20. PMID: 30709367.
      View in: PubMed
    6. Gulei D, Raduly L, Berindan-Neagoe I, Calin GA. CRISPR-based RNA editing: diagnostic applications and therapeutic options. Expert Rev Mol Diagn. 2019 02; 19(2):83-88. PMID: 30632384.
      View in: PubMed
    7. Varkaris A, Katsiampoura A, Davis JS, Shah N, Lam M, Frias RL, Ivan C, Shimizu M, Morris J, Menter D, Overman M, Tran H, Heymach J, Chun YS, Vauthey JN, Calin G, Kopetz S. Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer. Br J Cancer. 2019 Feb; 120(3):340-345. PMID: 30636774.
      View in: PubMed
    8. Calin GA. Preface for GCC Special Issue on noncoding RNAs, noncoding DNAs, and genome editing. Genes Chromosomes Cancer. 2019 04; 58(4):189-190. PMID: 30474323.
      View in: PubMed
    9. Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I. miR-181a/b therapy in lung cancer: reality or myth? Mol Oncol. 2019 Jan; 13(1):9-25. PMID: 30548184.
      View in: PubMed
    10. Calin GA. The noncoding RNA revolution-three decades and still going strong! Mol Oncol. 2019 Jan; 13(1):3. PMID: 30614645.
      View in: PubMed
    11. Van Roosbroeck K, Bayraktar R, Calin GA. Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR. Methods Mol Biol. 2019; 1881:267-276. PMID: 30350212.
      View in: PubMed
    12. Diniz MG, França JA, Vilas-Boas FAS, de Souza FTA, Calin GA, Gomez RS, de Sousa SF, Gomes CC. The long noncoding RNA KIAA0125 is upregulated in ameloblastomas. Pathol Res Pract. 2019 Mar; 215(3):466-469. PMID: 30595406.
      View in: PubMed
    13. Mitra K, Feist WN, Anfossi S, Fuentes-Mattei E, Almeida MI, Kim JJ, Calin GA, Warmflash A. S-MiRAGE: A Quantitative, Secreted RNA-Based Reporter of Gene Expression and Cell Persistence. ACS Synth Biol. 2019 Jan 18; 8(1):25-33. PMID: 30550267.
      View in: PubMed
    14. Mokhlis HA, Bayraktar R, Kabil NN, Caner A, Kahraman N, Rodriguez-Aguayo C, Zambalde EP, Sheng J, Karagoz K, Kanlikilicer P, Abdel Aziz AAH, Abdelghany TM, Ashour AA, Wong S, Gatza ML, Calin GA, Lopez-Berestein G, Ozpolat B. The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers. Mol Ther Nucleic Acids. 2019 Mar 01; 14:301-317. PMID: 30654191.
      View in: PubMed
    15. Kanlikilicer P, Bayraktar R, Denizli M, Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang X, Rodriguez-Aguayo C, El-Arabey AA, Kahraman N, Baydogan S, Ozkayar O, Gatza ML, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein G. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018 Dec; 38:100-112. PMID: 30487062.
      View in: PubMed
    16. Van Roosbroeck K, Bayraktar R, Calin S, Bloehdorn J, Dragomir MP, Okubo K, Bertilaccio MTS, Zupo S, You MJ, Gaidano G, Rossi D, Chen SS, Chiorazzi N, Thompson PA, Ferrajoli A, Bertoni F, Stilgenbauer S, Keating MJ, Calin GA. The involvement of microRNA in the pathogenesis of Richter syndrome. Haematologica. 2019 May; 104(5):1004-1015. PMID: 30409799.
      View in: PubMed
    17. Foßelteder J, Calin GA, Pichler M. Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer. Expert Opin Ther Targets. 2018 12; 22(12):973-976. PMID: 30365347.
      View in: PubMed
    18. Fu X, Calin GA. miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics. EBioMedicine. 2018 11; 37:17-18. PMID: 30337246.
      View in: PubMed
    19. Shen P, Reineke LC, Knutsen E, Chen M, Pichler M, Ling H, Calin GA. Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling. Mol Oncol. 2018 11; 12(11):1856-1870. PMID: 30221473.
      View in: PubMed
    20. Dragomir M, Calin GA. Corrigendum: Circular RNAs in Cancer - Lessons Learned From microRNAs. Front Oncol. 2018; 8:307. PMID: 30280089.
      View in: PubMed
    21. Xiao H, Shiu PKT, Shu J, Santulli G, Gheybi MK, Conn SJ, Bogard B, Hubé F, Taube JH, Mani SA, Song L, Calin GA, Zhang S. The Non-Coding RNA Journal Club: Highlights on Recent Papers-6. Noncoding RNA. 2018 Sep 18; 4(3). PMID: 30231579.
      View in: PubMed
    22. Dragomir MP, Calin GA. CpG island hypermethylation go circular (RNA). Oncotarget. 2018 Sep 04; 9(69):33052-33053. PMID: 30237846.
      View in: PubMed
    23. Anfossi S, Babayan A, Pantel K, Calin GA. Clinical utility of circulating non-coding RNAs - an update. Nat Rev Clin Oncol. 2018 09; 15(9):541-563. PMID: 29784926.
      View in: PubMed
    24. Monroig-Bosque PDC, Shah MY, Fu X, Fuentes-Mattei E, Ling H, Ivan C, Nouraee N, Huang B, Chen L, Pileczki V, Redis RS, Jung EJ, Zhang X, Lehrer M, Nagvekar R, Mafra ACP, Monroig-Bosque MDM, Irimie A, Rivera C, Dan Dumitru C, Berindan-Neagoe I, Nikonowicz EP, Zhang S, Calin GA. OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers. Sci Rep. 2018 Aug 30; 8(1):13106. PMID: 30166612.
      View in: PubMed
    25. Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 2018 Aug 17. PMID: 30102929.
      View in: PubMed
    26. Dragomir MP, Knutsen E, Calin GA. SnapShot: Unconventional miRNA Functions. Cell. 2018 08 09; 174(4):1038-1038.e1. PMID: 30096304.
      View in: PubMed
    27. Marks DL, Olson RL, Urrutia R, Billadeau DD, Roy N, Calin GA, Fabbri M, Koutsioumpa M, Iliopoulos D, Ordog T, Huebert R, Sarmento O, Bamidele AO, Faubion W, Lomberk GL, Siveke J, Ahuja N, Iovanna J, Hlady RA, Robertson K, Kisiel J, Pin CL, Fernandez-Zapico ME. Epigenetics of gastrointestinal diseases: notes from a workshop. Epigenetics. 2018; 13(4):449-457. PMID: 30056798.
      View in: PubMed
    28. Abruzzo LV, Herling CD, Calin GA, Oakes C, Barron LL, Banks HE, Katju V, Keating MJ, Coombes KR. Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways. Haematologica. 2018 Dec; 103(12):2069-2078. PMID: 29976738.
      View in: PubMed
    29. Malpeli G, Barbi S, Tosadori G, Greco C, Zupo S, Pedron S, Brunelli M, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Calin GA, Scarpa A, Zamò A. MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways. Oncotarget. 2018 Jul 03; 9(51):29753-29771. PMID: 30038718.
      View in: PubMed
    30. Kabil N, Bayraktar R, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, Ozpolat B. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Breast Cancer Res Treat. 2018 Oct; 171(3):593-605. PMID: 29971628.
      View in: PubMed
    31. Manga G, Calin GA, Manuc M, Droc G, Tudor S. New Definitions of Sepsis and the Quest for Specific Biomarkers. Are the miRNAs the Answer? Chirurgia (Bucur). 2018 Jul-Aug; 113(4):464-468. PMID: 30183576.
      View in: PubMed
    32. Dragomir M, Mafra ACP, Dias SMG, Vasilescu C, Calin GA. Using microRNA Networks to Understand Cancer. Int J Mol Sci. 2018 Jun 26; 19(7). PMID: 29949872.
      View in: PubMed
    33. Silva AM, Almeida MI, Teixeira JH, Ivan C, Oliveira J, Vasconcelos D, Neves N, Ribeiro-Machado C, Cunha C, Barbosa MA, Calin GA, Santos SG. Profiling the circulating miRnome reveals a temporal regulation of the bone injury response. Theranostics. 2018; 8(14):3902-3917. PMID: 30083269.
      View in: PubMed
    34. Dragomir M, Calin GA. Circular RNAs in Cancer - Lessons Learned From microRNAs. Front Oncol. 2018; 8:179. PMID: 29911069.
      View in: PubMed
    35. Bayraktar R, Ivan C, Bayraktar E, Kanlikilicer P, Kabil NN, Kahraman N, Mokhlis HA, Karakas D, Rodriguez-Aguayo C, Arslan A, Sheng J, Wong S, Lopez-Berestein G, Calin GA, Ozpolat B. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion. Clin Cancer Res. 2018 Sep 01; 24(17):4225-4241. PMID: 29748184.
      View in: PubMed
    36. Chaganty BKR, Qiu S, Gest A, Lu Y, Ivan C, Calin GA, Weiner LM, Fan Z. Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFN? secretion. Cancer Lett. 2018 Aug 28; 430:47-56. PMID: 29746929.
      View in: PubMed
    37. Dragomir M, Chen B, Fu X, Calin GA. Key questions about the checkpoint blockade-are microRNAs an answer? Cancer Biol Med. 2018 May; 15(2):103-115. PMID: 29951335.
      View in: PubMed
    38. Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA. Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res. 2018 04; 28(4):432-447. PMID: 29567676.
      View in: PubMed
    39. Dragomir M, Chen B, Calin GA. Exosomal lncRNAs as new players in cell-to-cell communication. Transl Cancer Res. 2018 Mar; 7(Suppl 2):S243-S252. PMID: 30148073.
      View in: PubMed
    40. Calin GA, Van Roosbroeck K. Preface. Cancer Metastasis Rev. 2018 03; 37(1):3-4. PMID: 29285656.
      View in: PubMed
    41. Pop-Bica C, Pintea S, Cojocneanu-Petric R, Del Sal G, Piazza S, Wu ZH, Alencar AJ, Lossos IS, Berindan-Neagoe I, Calin GA. MiR-181 family-specific behavior in different cancers: a meta-analysis view. Cancer Metastasis Rev. 2018 03; 37(1):17-32. PMID: 29327093.
      View in: PubMed
    42. Ultimo S, Martelli AM, Zauli G, Vitale M, Calin GA, Neri LM. Roles and clinical implications of microRNAs in acute lymphoblastic leukemia. J Cell Physiol. 2018 Aug; 233(8):5642-5654. PMID: 29154447.
      View in: PubMed
    43. Ferreira AF, Calin GA, Picanço-Castro V, Kashima S, Covas DT, de Castro FA. Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator. J Cell Sci. 2018 02 21; 131(4). PMID: 29467236.
      View in: PubMed
    44. Del Vecchio F, Lee GH, Hawezi J, Bhome R, Pugh S, Sayan E, Thomas G, Packham G, Primrose J, Pichler M, Mirnezami A, Calin G, Bullock M. Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk. Cancer Lett. 2018 05 01; 421:94-102. PMID: 29458141.
      View in: PubMed
    45. Peng Y, Calin GA. Crucial role of non-coding RNAs in disease. Cancer Lett. 2018 04 28; 420:127-128. PMID: 29425682.
      View in: PubMed
    46. Velazquez-Torres G, Shoshan E, Ivan C, Huang L, Fuentes-Mattei E, Paret H, Kim SJ, Rodriguez-Aguayo C, Xie V, Brooks D, Jones SJM, Robertson AG, Calin G, Lopez-Berenstein G, Sood A, Bar-Eli M. A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression. Nat Commun. 2018 01 31; 9(1):461. PMID: 29386624.
      View in: PubMed
    47. Calin GA. Featuring the special issue Guest Editor. Cancer Lett. 2018 06 01; 423:27. PMID: 29330106.
      View in: PubMed
    48. Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M. Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2018 01 08; 9(1):160. PMID: 29311577.
      View in: PubMed
    49. Anfossi S, Fu X, Nagvekar R, Calin GA. MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells. Adv Exp Med Biol. 2018; 1056:87-108. PMID: 29754176.
      View in: PubMed
    50. Nassar FJ, Talhouk R, Zgheib NK, Tfayli A, El Sabban M, El Saghir NS, Boulos F, Jabbour MN, Chalala C, Boustany RM, Kadara H, Zhang Z, Zheng Y, Joyce B, Hou L, Bazarbachi A, Calin G, Nasr R. microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis. Sci Rep. 2017 Dec 04; 7(1):16829. PMID: 29203780.
      View in: PubMed
    51. Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M. Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2017 11 27; 8(1):1801. PMID: 29180617.
      View in: PubMed
    52. Bras JP, Silva AM, Calin GA, Barbosa MA, Santos SG, Almeida MI. miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells. PLoS One. 2017; 12(11):e0188530. PMID: 29166412.
      View in: PubMed
    53. Amorim MG, Valieris R, Drummond RD, Pizzi MP, Freitas VM, Sinigaglia-Coimbra R, Calin GA, Pasqualini R, Arap W, Silva IT, Dias-Neto E, Nunes DN. A total transcriptome profiling method for plasma-derived extracellular vesicles: applications for liquid biopsies. Sci Rep. 2017 10 31; 7(1):14395. PMID: 29089558.
      View in: PubMed
    54. Bayraktar R, Van Roosbroeck K, Calin GA. Cell-to-cell communication: microRNAs as hormones. Mol Oncol. 2017 12; 11(12):1673-1686. PMID: 29024380.
      View in: PubMed
    55. Wu X, Tudoran OM, Calin GA, Ivan M. The Many Faces of Long Noncoding RNAs in Cancer. Antioxid Redox Signal. 2018 Sep 20; 29(9):922-935. PMID: 28793797.
      View in: PubMed
    56. Berrout J, Kyriakopoulou E, Moparthi L, Hogea AS, Berrout L, Ivan C, Lorger M, Boyle J, Peers C, Muench S, Gomez JE, Hu X, Hurst C, Hall T, Umamaheswaran S, Wesley L, Gagea M, Shires M, Manfield I, Knowles MA, Davies S, Suhling K, Gonzalez YT, Carragher N, Macleod K, Abbott NJ, Calin GA, Gamper N, Zygmunt PM, Timsah Z. TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p. Nat Commun. 2017 10 16; 8(1):947. PMID: 29038531.
      View in: PubMed
    57. Shen J, Hodges TR, Song R, Gong Y, Calin GA, Heimberger AB, Zhao H. Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma. Mol Carcinog. 2018 Jan; 57(1):137-141. PMID: 28926136.
      View in: PubMed
    58. Kalariya N, Brassil K, Calin G. MicroRNAs: Clinical Trials and Potential Applications?. Clin J Oncol Nurs. 2017 Oct 01; 21(5):554-559. PMID: 28945717.
      View in: PubMed
    59. Jacobs DI, Liu Y, Gabrusiewicz K, Tsavachidis S, Armstrong GN, Zhou R, Wei J, Ivan C, Calin G, Molinaro AM, Rice T, Bracci PM, Hansen HM, Wiencke JK, Wrensch MR, Heimberger AB, Bondy ML. Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients. J Neurooncol. 2018 Jan; 136(1):33-39. PMID: 28965162.
      View in: PubMed
    60. Shen P, Pichler M, Chen M, Calin GA, Ling H. To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer. Int J Mol Sci. 2017 Sep 20; 18(9). PMID: 28930145.
      View in: PubMed
    61. Terracciano D, Terreri S, de Nigris F, Costa V, Calin GA, Cimmino A. The role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer. Biochim Biophys Acta Rev Cancer. 2017 Dec; 1868(2):449-455. PMID: 28916343.
      View in: PubMed
    62. Rodriguez-Aguayo C, Monroig PDC, Redis RS, Bayraktar E, Almeida MI, Ivan C, Fuentes-Mattei E, Rashed MH, Chavez-Reyes A, Ozpolat B, Mitra R, Sood AK, Calin GA, Lopez-Berestein G. Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer. Cell Discov. 2017; 3:17029. PMID: 28904816.
      View in: PubMed
    63. Bellido F, Sowada N, Mur P, Lázaro C, Pons T, Valdés-Mas R, Pineda M, Aiza G, Iglesias S, Soto JL, Urioste M, Caldés T, Balbín M, Blay P, Rueda D, Durán M, Valencia A, Moreno V, Brunet J, Blanco I, Navarro M, Calin GA, Borck G, Puente XS, Capellá G, Valle L. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer. Gastroenterology. 2018 01; 154(1):181-194.e20. PMID: 28912018.
      View in: PubMed
    64. Figueroa J, Phillips LM, Shahar T, Hossain A, Gumin J, Kim H, Bean AJ, Calin GA, Fueyo J, Walters ET, Kalluri R, Verhaak RG, Lang FF. Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. Cancer Res. 2017 11 01; 77(21):5808-5819. PMID: 28855213.
      View in: PubMed
    65. Vasilescu C, Dragomir M, Tanase M, Giza D, Purnichescu-Purtan R, Chen M, Yeung SJ, Calin GA. Circulating miRNAs in sepsis-A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis. PLoS One. 2017; 12(8):e0183334. PMID: 28820886.
      View in: PubMed
    66. Van Roosbroeck K, Calin GA. Cancer Hallmarks and MicroRNAs: The Therapeutic Connection. Adv Cancer Res. 2017; 135:119-149. PMID: 28882220.
      View in: PubMed
    67. Fabris L, Calin GA. Understanding the Genomic Ultraconservations: T-UCRs and Cancer. Int Rev Cell Mol Biol. 2017; 333:159-172. PMID: 28729024.
      View in: PubMed
    68. Marini A, Lena AM, Panatta E, Ivan C, Han L, Liang H, Annicchiarico-Petruzzelli M, Di Daniele N, Calin GA, Candi E, Melino G. Ultraconserved long non-coding RNA uc.63 in breast cancer. Oncotarget. 2017 May 30; 8(22):35669-35680. PMID: 27447964.
      View in: PubMed
    69. Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J, Gafà R, Spizzo R, Nicoloso MS, Paranjape AN, Shariati M, Tiron A, Yeh JJ, Teruel-Montoya R, Xiao L, Melo SA, Menter D, Jiang ZQ, Flores ER, Negrini M, Goel A, Bar-Eli M, Mani SA, Liu CG, Lopez-Berestein G, Berindan-Neagoe I, Esteller M, Kopetz S, Lanza G, Calin GA. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biol. 2017 05 24; 18(1):98. PMID: 28535802.
      View in: PubMed
    70. Stiegelbauer V, Vychytilova-Faltejskova P, Karbiener M, Pehserl AM, Reicher A, Resel M, Heitzer E, Ivan C, Bullock M, Ling H, Deutsch A, Wulf-Goldenberg A, Adiprasito JB, Stoeger H, Haybaeck J, Svoboda M, Stotz M, Hoefler G, Slaby O, Calin GA, Gerger A, Pichler M. miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5. Clin Cancer Res. 2017 Sep 01; 23(17):5255-5266. PMID: 28533224.
      View in: PubMed
    71. Silva AM, Almeida MI, Teixeira JH, Maia AF, Calin GA, Barbosa MA, Santos SG. Dendritic Cell-derived Extracellular Vesicles mediate Mesenchymal Stem/Stromal Cell recruitment. Sci Rep. 2017 05 10; 7(1):1667. PMID: 28490808.
      View in: PubMed
    72. Ling H, Girnita L, Buda O, Calin GA. Non-coding RNAs: the cancer genome dark matter that matters! Clin Chem Lab Med. 2017 May 01; 55(5):705-714. PMID: 27988500.
      View in: PubMed
    73. Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, Ciccone M, Kargin OA, Zhang X, Mur P, do Amaral NS, Chen M, Tarrand JJ, Lupu F, Ferrajoli A, Keating MJ, Vasilescu C, Yeung SJ, Calin GA. Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBioMedicine. 2017 Jun; 20:182-192. PMID: 28465156.
      View in: PubMed
    74. Rashed MH, Kanlikilicer P, Rodriguez-Aguayo C, Pichler M, Bayraktar R, Bayraktar E, Ivan C, Filant J, Silva A, Aslan B, Denizli M, Mitra R, Ozpolat B, Calin GA, Sood AK, Abd-Ellah MF, Helal GK, Berestein GL. Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs. Oncotarget. 2017 Mar 21; 8(12):20145-20164. PMID: 28423620.
      View in: PubMed
    75. Smolle MA, Bauernhofer T, Pummer K, Calin GA, Pichler M. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer. Int J Mol Sci. 2017 Feb 22; 18(2). PMID: 28241429.
      View in: PubMed
    76. Smolle MA, Calin HN, Pichler M, Calin GA. Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics. FEBS J. 2017 07; 284(13):1952-1966. PMID: 28132417.
      View in: PubMed
    77. Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N, Aslan B, Oguztuzun S, Ulasli M, Arslan A, Calin G, Lopez-Berestein G, Ozpolat B. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget. 2017 Feb 14; 8(7):11641-11658. PMID: 28036267.
      View in: PubMed
    78. Bottai G, Diao L, Baggerly KA, Paladini L, Gyorffy B, Raschioni C, Pusztai L, Calin GA, Santarpia L. Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer. Int J Mol Sci. 2017 Jan 19; 18(1). PMID: 28106823.
      View in: PubMed
    79. Lee NK, Lee JH, Ivan C, Ling H, Zhang X, Park CH, Calin GA, Lee SK. MALAT1 promoted invasiveness of gastric adenocarcinoma. BMC Cancer. 2017 01 11; 17(1):46. PMID: 28077118.
      View in: PubMed
    80. Redis RS, Calin GA. SnapShot: Non-coding RNAs and Metabolism. Cell Metab. 2017 01 10; 25(1):220-220.e1. PMID: 28076764.
      View in: PubMed
    81. Van Roosbroeck K, Fanini F, Setoyama T, Ivan C, Rodriguez-Aguayo C, Fuentes-Mattei E, Xiao L, Vannini I, Redis RS, D'Abundo L, Zhang X, Nicoloso MS, Rossi S, Gonzalez-Villasana V, Rupaimoole R, Ferracin M, Morabito F, Neri A, Ruvolo PP, Ruvolo VR, Pecot CV, Amadori D, Abruzzo L, Calin S, Wang X, You MJ, Ferrajoli A, Orlowski R, Plunkett W, Lichtenberg TM, Davuluri RV, Berindan-Neagoe I, Negrini M, Wistuba II, Kantarjian HM, Sood AK, Lopez-Berestein G, Keating MJ, Fabbri M, Calin GA. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers. Clin Cancer Res. 2017 06 01; 23(11):2891-2904. PMID: 27903673.
      View in: PubMed
    82. Ohtsuka M, Ling H, Ivan C, Pichler M, Matsushita D, Goblirsch M, Stiegelbauer V, Shigeyasu K, Zhang X, Chen M, Vidhu F, Bartholomeusz GA, Toiyama Y, Kusunoki M, Doki Y, Mori M, Song S, Gunther JR, Krishnan S, Slaby O, Goel A, Ajani JA, Radovich M, Calin GA. H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-ß-Catenin Signaling in Colorectal Cancer. EBioMedicine. 2016 Nov; 13:113-124. PMID: 27789274.
      View in: PubMed
    83. Giza DE, Fuentes-Mattei E, Bullock MD, Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C, Calin GA. Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications. Cell Death Differ. 2016 12; 23(12):1906-1918. PMID: 27740627.
      View in: PubMed
    84. Kanlikilicer P, Rashed MH, Bayraktar R, Mitra R, Ivan C, Aslan B, Zhang X, Filant J, Silva AM, Rodriguez-Aguayo C, Bayraktar E, Pichler M, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein G. Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells. Cancer Res. 2016 12 15; 76(24):7194-7207. PMID: 27742688.
      View in: PubMed
    85. Gomes CC, de Sousa SF, Calin GA, Gomez RS. The emerging role of long noncoding RNAs in oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Feb; 123(2):235-241. PMID: 27989708.
      View in: PubMed
    86. Shah MY, Ferrajoli A, Sood AK, Lopez-Berestein G, Calin GA. microRNA Therapeutics in Cancer - An Emerging Concept. EBioMedicine. 2016 Oct; 12:34-42. PMID: 27720213.
      View in: PubMed
    87. Park JH, Theodoratou E, Calin GA, Shin JI. From cell biology to immunology: Controlling metastatic progression of cancer via microRNA regulatory networks. Oncoimmunology. 2016; 5(11):e1230579. PMID: 27999740.
      View in: PubMed
    88. Pichler M, Stiegelbauer V, Vychytilova-Faltejskova P, Ivan C, Ling H, Winter E, Zhang X, Goblirsch M, Wulf-Goldenberg A, Ohtsuka M, Haybaeck J, Svoboda M, Okugawa Y, Gerger A, Hoefler G, Goel A, Slaby O, Calin GA. Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis. Clin Cancer Res. 2017 Mar 01; 23(5):1323-1333. PMID: 27601590.
      View in: PubMed
    89. Cerk S, Schwarzenbacher D, Adiprasito JB, Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA, Pichler M. Current Status of Long Non-Coding RNAs in Human Breast Cancer. Int J Mol Sci. 2016 Sep 06; 17(9). PMID: 27608009.
      View in: PubMed
    90. Dragomir M, Petrescu DGE, Manga GE, Calin GA, Vasilescu C. Patients After Splenectomy: Old Risks and New Perspectives. Chirurgia (Bucur). 2016 Sept-Oct; 111(5):393-399. PMID: 27819637.
      View in: PubMed
    91. Jiang J, Azevedo-Pouly AC, Redis RS, Lee EJ, Gusev Y, Allard D, Sutaria DS, Badawi M, Elgamal OA, Lerner MR, Brackett DJ, Calin GA, Schmittgen TD. Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. Oncotarget. 2016 Aug 16; 7(33):53165-53177. PMID: 27363020.
      View in: PubMed
    92. Vasilescu C, Tanase M, Dragomir M, Calin GA. From mobility to crosstalk. A model of intracellular miRNAs motion may explain the RNAs interaction mechanism on the basis of target subcellular localization. Math Biosci. 2016 10; 280:50-61. PMID: 27498347.
      View in: PubMed
    93. de Melo Maia B, Rodrigues IS, Akagi EM, Soares do Amaral N, Ling H, Monroig P, Soares FA, Calin GA, Rocha RM. MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. Oncotarget. 2016 08 02; 7(31):49217-49231. PMID: 27359057.
      View in: PubMed
    94. Anfossi S, Calin GA. Hodgkin Lymphoma Cells Have a Specific Long Noncoding RNA Expression Pattern. Am J Pathol. 2016 Sep; 186(9):2251-3. PMID: 27456130.
      View in: PubMed
    95. Paladini L, Fabris L, Bottai G, Raschioni C, Calin GA, Santarpia L. Targeting microRNAs as key modulators of tumor immune response. J Exp Clin Cancer Res. 2016 Jun 27; 35:103. PMID: 27349385.
      View in: PubMed
    96. Rozovski U, Hazan-Halevy I, Calin G, Harris D, Li P, Liu Z, Keating MJ, Estrov Z. Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome. J Vis Exp. 2016 06 15; (112). PMID: 27341356.
      View in: PubMed
    97. Lupini L, Pepe F, Ferracin M, Braconi C, Callegari E, Pagotto S, Spizzo R, Zagatti B, Lanuti P, Fornari F, Ghasemi R, Mariani-Costantini R, Bolondi L, Gramantieri L, Calin GA, Sabbioni S, Visone R, Veronese A, Negrini M. Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma. Oncotarget. 2016 May 24; 7(21):31361-71. PMID: 27120784.
      View in: PubMed
    98. Chaluvally-Raghavan P, Jeong KJ, Pradeep S, Silva AM, Yu S, Liu W, Moss T, Rodriguez-Aguayo C, Zhang D, Ram P, Liu J, Lu Y, Lopez-Berestein G, Calin GA, Sood AK, Mills GB. Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer. Cell Rep. 2016 05 17; 15(7):1493-1504. PMID: 27160903.
      View in: PubMed
    99. Van Roosbroeck K, Calin GA. When kissing (disease) counts. Blood. 2016 Apr 21; 127(16):1947-8. PMID: 27103742.
      View in: PubMed
    100. Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Wu W, Calin GA, Krishnamurthy S, Zhang XH, Buchholz TA, Ueno NT, Reuben JM, Woodward WA. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. J Natl Cancer Inst. 2016 08; 108(8). PMID: 27075851.
      View in: PubMed
    101. Olivieri M, Ferro M, Terreri S, Durso M, Romanelli A, Avitabile C, De Cobelli O, Messere A, Bruzzese D, Vannini I, Marinelli L, Novellino E, Zhang W, Incoronato M, Ilardi G, Staibano S, Marra L, Franco R, Perdonà S, Terracciano D, Czerniak B, Liguori GL, Colonna V, Fabbri M, Febbraio F, Calin GA, Cimmino A. Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis. Oncotarget. 2016 Apr 12; 7(15):20636-54. PMID: 26943042.
      View in: PubMed
    102. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M. Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression. Cancer Cell. 2016 Apr 11; 29(4):607-608. PMID: 27070707.
      View in: PubMed
    103. Redis RS, Calin GA. The interplay between lnRNAs, SNPs, and protein complexes - what does it mean for cancer metabolism? Mol Cell Oncol. 2016 Jul; 3(4):e1166308. PMID: 27652320.
      View in: PubMed
    104. Dwivedi SK, Mustafi SB, Mangala LS, Jiang D, Pradeep S, Rodriguez-Aguayo C, Ling H, Ivan C, Mukherjee P, Calin GA, Lopez-Berestein G, Sood AK, Bhattacharya R. Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotarget. 2016 Mar 22; 7(12):15093-104. PMID: 26918603.
      View in: PubMed
    105. Almeida MI, Calin GA. The miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles. Genome Med. 2016 Mar 17; 8(1):29. PMID: 26988859.
      View in: PubMed
    106. Sun Y, Liu Y, Cogdell D, Calin GA, Sun B, Kopetz S, Hamilton SR, Zhang W. Examining plasma microRNA markers for colorectal cancer at different stages. Oncotarget. 2016 Mar 08; 7(10):11434-49. PMID: 26863633.
      View in: PubMed
    107. Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, Fernandez AF, Valledor L, Van Roosbroeck K, Chang S, Shah M, Kinnebrew G, Han L, Atlasi Y, Cheung LH, Huang GY, Monroig P, Ramirez MS, Catela Ivkovic T, Van L, Ling H, Gafà R, Kapitanovic S, Lanza G, Bankson JA, Huang P, Lai SY, Bast RC, Rosenblum MG, Radovich M, Ivan M, Bartholomeusz G, Liang H, Fraga MF, Widger WR, Hanash S, Berindan-Neagoe I, Lopez-Berestein G, Ambrosio ALB, Gomes Dias SM, Calin GA. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):640. PMID: 28934601.
      View in: PubMed
    108. Rupaimoole R, Calin GA, Lopez-Berestein G, Sood AK. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Cancer Discov. 2016 Mar; 6(3):235-46. PMID: 26865249.
      View in: PubMed
    109. Van Roosbroeck K, Calin GA. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies? Semin Oncol. 2016 Apr; 43(2):209-14. PMID: 27040698.
      View in: PubMed
    110. Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, Fernandez AF, Valledor L, Van Roosbroeck K, Chang S, Shah M, Kinnebrew G, Han L, Atlasi Y, Cheung LH, Huang GY, Monroig P, Ramirez MS, Catela Ivkovic T, Van L, Ling H, Gafà R, Kapitanovic S, Lanza G, Bankson JA, Huang P, Lai SY, Bast RC, Rosenblum MG, Radovich M, Ivan M, Bartholomeusz G, Liang H, Fraga MF, Widger WR, Hanash S, Berindan-Neagoe I, Lopez-Berestein G, Ambrosio ALB, Gomes Dias SM, Calin GA. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534. PMID: 26853146.
      View in: PubMed
    111. Fabris L, Ceder Y, Chinnaiyan AM, Jenster GW, Sorensen KD, Tomlins S, Visakorpi T, Calin GA. The Potential of MicroRNAs as Prostate Cancer Biomarkers. Eur Urol. 2016 08; 70(2):312-22. PMID: 26806656.
      View in: PubMed
    112. Fabris L, Calin GA. Circulating free xeno-microRNAs - The new kids on the block. Mol Oncol. 2016 Mar; 10(3):503-8. PMID: 26860056.
      View in: PubMed
    113. de la Parra C, Castillo-Pichardo L, Cruz-Collazo A, Cubano L, Redis R, Calin GA, Dharmawardhane S. Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein. Nutr Cancer. 2016; 68(1):154-64. PMID: 26771440.
      View in: PubMed
    114. Almeida MI, Silva AM, Vasconcelos DM, Almeida CR, Caires H, Pinto MT, Calin GA, Santos SG, Barbosa MA. miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis. Oncotarget. 2016 Jan 05; 7(1):7-22. PMID: 26683705.
      View in: PubMed
    115. Vitale C, Falchi L, Ten Hacken E, Gao H, Shaim H, Van Roosbroeck K, Calin G, O'Brien S, Faderl S, Wang X, Wierda WG, Rezvani K, Reuben JM, Burger JA, Keating MJ, Ferrajoli A. Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics. Clin Cancer Res. 2016 05 15; 22(10):2359-67. PMID: 26733610.
      View in: PubMed
    116. Zhang X, Lopez-Berestein G, Sood AK, Calin GA. Profiling Long Noncoding RNA Expression Using Custom-Designed Microarray. Methods Mol Biol. 2016; 1402:33-41. PMID: 26721482.
      View in: PubMed
    117. Ciccone M, Calin GA. MicroRNAs in Chronic Lymphocytic Leukemia: An Old Disease with New Genetic Insights. Microrna. 2016; 5(2):106-112. PMID: 27568792.
      View in: PubMed
    118. Kong LY, Wei J, Fuller GN, Schrand B, Gabrusiewicz K, Zhou S, Rao G, Calin G, Gilboa E, Heimberger AB. Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. Oncoimmunology. 2016 May; 5(5):e1117739. PMID: 27467917.
      View in: PubMed
    119. Cortez MA, Valdecanas D, Niknam S, Peltier HJ, Diao L, Giri U, Komaki R, Calin GA, Gomez DR, Chang JY, Heymach JV, Bader AG, Welsh JW. In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation. Mol Ther Nucleic Acids. 2015 Dec 15; 4:e270. PMID: 26670277.
      View in: PubMed
    120. Catana CS, Calin GA, Berindan-Neagoe I. Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players? Front Med (Lausanne). 2015; 2:85. PMID: 26697428.
      View in: PubMed
    121. Wei J, Nduom EK, Kong LY, Hashimoto Y, Xu S, Gabrusiewicz K, Ling X, Huang N, Qiao W, Zhou S, Ivan C, Fuller GN, Gilbert MR, Overwijk W, Calin GA, Heimberger AB. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro Oncol. 2016 05; 18(5):639-48. PMID: 26658052.
      View in: PubMed
    122. Rupaimoole R, Lee J, Haemmerle M, Ling H, Previs RA, Pradeep S, Wu SY, Ivan C, Ferracin M, Dennison JB, Millward NMZ, Nagaraja AS, Gharpure KM, McGuire M, Sam N, Armaiz-Pena GN, Sadaoui NC, Rodriguez-Aguayo C, Calin GA, Drapkin RI, Kovacs J, Mills GB, Zhang W, Lopez-Berestein G, Bhattacharya PK, Sood AK. Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. Cell Rep. 2015 Dec 22; 13(11):2395-2402. PMID: 26686630.
      View in: PubMed
    123. Tuna M, Machado AS, Calin GA. Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases. Genes Chromosomes Cancer. 2016 Mar; 55(3):193-214. PMID: 26651018.
      View in: PubMed
    124. Cortez MA, Ivan C, Valdecanas D, Wang X, Peltier HJ, Ye Y, Araujo L, Carbone DP, Shilo K, Giri DK, Kelnar K, Martin D, Komaki R, Gomez DR, Krishnan S, Calin GA, Bader AG, Welsh JW. PDL1 Regulation by p53 via miR-34. J Natl Cancer Inst. 2016 Jan; 108(1). PMID: 26577528.
      View in: PubMed
    125. De Mattos-Arruda L, Bottai G, Nuciforo PG, Di Tommaso L, Giovannetti E, Peg V, Losurdo A, Pérez-Garcia J, Masci G, Corsi F, Cortés J, Seoane J, Calin GA, Santarpia L. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. Oncotarget. 2015 Nov 10; 6(35):37269-80. PMID: 26452030.
      View in: PubMed
    126. Silva A, Bullock M, Calin G. The Clinical Relevance of Long Non-Coding RNAs in Cancer. Cancers (Basel). 2015 Oct 27; 7(4):2169-82. PMID: 26516918.
      View in: PubMed
    127. Sawada G, Niida A, Hirata H, Komatsu H, Uchi R, Shimamura T, Takahashi Y, Kurashige J, Matsumura T, Ueo H, Takano Y, Ueda M, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Yamasaki M, Tanaka F, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Tanaka Y, Calin G, Miyano S, Doki Y, Mori M, Mimori K. An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma. PLoS One. 2015; 10(10):e0139808. PMID: 26465158.
      View in: PubMed
    128. Chira S, Jackson CS, Oprea I, Ozturk F, Pepper MS, Diaconu I, Braicu C, Raduly LZ, Calin GA, Berindan-Neagoe I. Progresses towards safe and efficient gene therapy vectors. Oncotarget. 2015 Oct 13; 6(31):30675-703. PMID: 26362400.
      View in: PubMed
    129. Ciccone M, Calin GA. MicroRNAs in Myeloid Hematological Malignancies. Curr Genomics. 2015 Oct; 16(5):336-48. PMID: 27047254.
      View in: PubMed
    130. Bucur O, Almasan A, Zubarev R, Friedman M, Nicolson GL, Sumazin P, Leabu M, Nikolajczyk BS, Avram D, Kunej T, Calin GA, Godwin AK, Adami HO, Zaphiropoulos PG, Richardson DR, Schmitt-Ulms G, Westerblad H, Keniry M, Grau GE, Carbonetto S, Stan RV, Popa-Wagner A, Takhar K, Baron BW, Galardy PJ, Yang F, Data D, Fadare O, Yeo KJ, Gabreanu GR, Andrei S, Soare GR, Nelson MA, Liehn EA. An updated h-index measures both the primary and total scientific output of a researcher. Discoveries (Craiova). 2015 Jul-Sep; 3(3). PMID: 26504901.
      View in: PubMed
    131. Schwarzenbach H, da Silva AM, Calin G, Pantel K. Data Normalization Strategies for MicroRNA Quantification. Clin Chem. 2015 Nov; 61(11):1333-42. PMID: 26408530.
      View in: PubMed
    132. Nduom EK, Wei J, Yaghi NK, Huang N, Kong LY, Gabrusiewicz K, Ling X, Zhou S, Ivan C, Chen JQ, Burks JK, Fuller GN, Calin GA, Conrad CA, Creasy C, Ritthipichai K, Radvanyi L, Heimberger AB. PD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol. 2016 Feb; 18(2):195-205. PMID: 26323609.
      View in: PubMed
    133. Ohtsuka M, Ling H, Doki Y, Mori M, Calin GA. MicroRNA Processing and Human Cancer. J Clin Med. 2015 Aug 21; 4(8):1651-67. PMID: 26308063.
      View in: PubMed
    134. de Melo Maia B, Ling H, Monroig P, Ciccone M, Soares FA, Calin GA, Rocha RM. Design of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma. Mol Cell Probes. 2015 Dec; 29(6):420-426. PMID: 26297962.
      View in: PubMed
    135. Pichler M, Calin GA. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer. 2015 Aug 11; 113(4):569-73. PMID: 26158421.
      View in: PubMed
    136. García-Cruz R, Camats M, Calin GA, Liu CG, Volinia S, Taccioli C, Croce CM, Bach-Elias M. The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model. BMC Med Genet. 2015 Jul 03; 16:46. PMID: 26138095.
      View in: PubMed
    137. Bullock MD, Silva AM, Calin GA. Estrogen and breast cancer: can less mean more? Cell Cycle. 2015; 14(14):2197-8. PMID: 26090587.
      View in: PubMed
    138. Aslan B, Monroig P, Hsu MC, Pena GA, Rodriguez-Aguayo C, Gonzalez-Villasana V, Rupaimoole R, Nagaraja AS, Mangala S, Han HD, Yuca E, Wu SY, Ivan C, Moss TJ, Ram PT, Wang H, Gol-Chambers A, Ozkayar O, Kanlikilicer P, Fuentes-Mattei E, Kahraman N, Pradeep S, Ozpolat B, Tucker S, Hung MC, Baggerly K, Bartholomeusz G, Calin G, Sood AK, Lopez-Berestein G. The ZNF304-integrin axis protects against anoikis in cancer. Nat Commun. 2015 Jun 17; 6:7351. PMID: 26081979.
      View in: PubMed
    139. Salameh A, Lee AK, Cardó-Vila M, Nunes DN, Efstathiou E, Staquicini FI, Dobroff AS, Marchiò S, Navone NM, Hosoya H, Lauer RC, Wen S, Salmeron CC, Hoang A, Newsham I, Lima LA, Carraro DM, Oliviero S, Kolonin MG, Sidman RL, Do KA, Troncoso P, Logothetis CJ, Brentani RR, Calin GA, Cavenee WK, Dias-Neto E, Pasqualini R, Arap W. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci U S A. 2015 Jul 07; 112(27):8403-8. PMID: 26080435.
      View in: PubMed
    140. Ye X, Fan F, Bhattacharya R, Bellister S, Boulbes DR, Wang R, Xia L, Ivan C, Zheng X, Calin GA, Wang J, Lu X, Ellis LM. VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells. Mol Cancer Res. 2015 Sep; 13(9):1274-82. PMID: 26041938.
      View in: PubMed
    141. Bullock MD, Silva AM, Kanlikilicer-Unaldi P, Filant J, Rashed MH, Sood AK, Lopez-Berestein G, Calin GA. Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer. Noncoding RNA. 2015 Jun 03; 1(1):53-68. PMID: 29861415.
      View in: PubMed
    142. Challagundla KB, Wise PM, Neviani P, Chava H, Murtadha M, Xu T, Kennedy R, Ivan C, Zhang X, Vannini I, Fanini F, Amadori D, Calin GA, Hadjidaniel M, Shimada H, Jong A, Seeger RC, Asgharzadeh S, Goldkorn A, Fabbri M. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015 Jul; 107(7). PMID: 25972604.
      View in: PubMed
    143. Schwarzenbacher D, Stiegelbauer V, Deutsch A, Ress AL, Aigelsreiter A, Schauer S, Wagner K, Langsenlehner T, Resel M, Gerger A, Ling H, Ivan C, Calin GA, Hoefler G, Rinner B, Pichler M. Low spinophilin expression enhances aggressive biological behavior of breast cancer. Oncotarget. 2015 May 10; 6(13):11191-202. PMID: 25857299.
      View in: PubMed
    144. Ferrajoli A, Ivan C, Ciccone M, Shimizu M, Kita Y, Ohtsuka M, D'Abundo L, Qiang J, Lerner S, Nouraee N, Rabe KG, Rassenti LZ, Van Roosbroeck K, Manning JT, Yuan Y, Zhang X, Shanafelt TD, Wierda WG, Sabbioni S, Tarrand JJ, Estrov Z, Radovich M, Liang H, Negrini M, Kipps TJ, Kay NE, Keating M, Calin GA. Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine. 2015 Jun; 2(6):572-82. PMID: 26288818.
      View in: PubMed
    145. Nouraee N, Mowla SJ, Calin GA. Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy. Genes Chromosomes Cancer. 2015 Jun; 54(6):335-52. PMID: 25832733.
      View in: PubMed
    146. Bullock MD, Pickard K, Mitter R, Sayan AE, Primrose JN, Ivan C, Calin GA, Thomas GJ, Packham GK, Mirnezami AH. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs. Oncotarget. 2015 Mar 30; 6(9):7262-79. PMID: 25788261.
      View in: PubMed
    147. Ling H, Pickard K, Ivan C, Isella C, Ikuo M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, Vincent K, Pichler M, Stiegelbauer V, Hoefler G, Almeida MI, Hsiao A, Zhang X, Primrose J, Packham G, Liu K, Bojja K, Gafà R, Xiao L, Rossi S, Song JH, Vannini I, Fanini F, Kopetz S, Zweidler-McKay P, Wang X, Ionescu C, Irimie A, Fabbri M, Lanza G, Hamilton SR, Berindan-Neagoe I, Medico E, Mirnezami A, Calin GA, Nicoloso MS. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut. 2016 06; 65(6):977-989. PMID: 25804630.
      View in: PubMed
    148. Karjalainen K, Jaalouk DE, Bueso-Ramos C, Bover L, Sun Y, Kuniyasu A, Driessen WH, Cardó-Vila M, Rietz C, Zurita AJ, O'Brien S, Kantarjian HM, Cortes JE, Calin GA, Koivunen E, Arap W, Pasqualini R. Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens. Clin Cancer Res. 2015 Jul 01; 21(13):3041-51. PMID: 25779950.
      View in: PubMed
    149. Nunes DN, Dias-Neto E, Cardó-Vila M, Edwards JK, Dobroff AS, Giordano RJ, Mandelin J, Brentani HP, Hasselgren C, Yao VJ, Marchiò S, Pereira CA, Passetti F, Calin GA, Sidman RL, Arap W, Pasqualini R. Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch. Proc Natl Acad Sci U S A. 2015 Mar 24; 112(12):3770-5. PMID: 25775553.
      View in: PubMed
    150. Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, Hatzimichael E, Kirino Y, Honda S, Lally M, Ramratnam B, Comstock CE, Knudsen KE, Gomella L, Spaeth GL, Hark L, Katz LJ, Witkiewicz A, Rostami A, Jimenez SA, Hollingsworth MA, Yeh JJ, Shaw CA, McKenzie SE, Bray P, Nelson PT, Zupo S, Van Roosbroeck K, Keating MJ, Calin GA, Yeo C, Jimbo M, Cozzitorto J, Brody JR, Delgrosso K, Mattick JS, Fortina P, Rigoutsos I. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A. 2015 Mar 10; 112(10):E1106-15. PMID: 25713380.
      View in: PubMed
    151. Ciccone M, Calin GA, Perrotti D. From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies. Front Oncol. 2015; 5:21. PMID: 25763353.
      View in: PubMed
    152. Shoshan E, Mobley AK, Braeuer RR, Kamiya T, Huang L, Vasquez ME, Salameh A, Lee HJ, Kim SJ, Ivan C, Velazquez-Torres G, Nip KM, Zhu K, Brooks D, Jones SJ, Birol I, Mosqueda M, Wen YY, Eterovic AK, Sood AK, Hwu P, Gershenwald JE, Robertson AG, Calin GA, Markel G, Fidler IJ, Bar-Eli M. Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat Cell Biol. 2015 Mar; 17(3):311-21. PMID: 25686251.
      View in: PubMed
    153. Van Roosbroeck K, Verstovsek S, Calin GA. Long non-coding RNAs in primary myelofibrosis: the dark matter in hematopoietic progenitor cells? Leuk Lymphoma. 2015 Feb; 56(2):281-2. PMID: 25093380.
      View in: PubMed
    154. Ling H, Vincent K, Pichler M, Fodde R, Berindan-Neagoe I, Slack FJ, Calin GA. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene. 2015 Sep 24; 34(39):5003-11. PMID: 25619839.
      View in: PubMed
    155. Gonzalez-Villasana V, Fuentes-Mattei E, Ivan C, Dalton HJ, Rodriguez-Aguayo C, Fernandez-de Thomas RJ, Aslan B, Del C Monroig P, Velazquez-Torres G, Previs RA, Pradeep S, Kahraman N, Wang H, Kanlikilicer P, Ozpolat B, Calin G, Sood AK, Lopez-Berestein G. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer. Clin Cancer Res. 2015 May 01; 21(9):2127-37. PMID: 25595279.
      View in: PubMed
    156. Monroig-Bosque Pdel C, Rivera CA, Calin GA. MicroRNAs in cancer therapeutics: "from the bench to the bedside". Expert Opin Biol Ther. 2015; 15(10):1381-5. PMID: 26372796.
      View in: PubMed
    157. Giza DE, Calin GA. microRNA and Chronic Lymphocytic Leukemia. Adv Exp Med Biol. 2015; 889:23-40. PMID: 26658994.
      View in: PubMed
    158. Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin GA, Børresen-Dale AL, Santarpia L. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients. Clin Cancer Res. 2015 Mar 01; 21(5):1207-14. PMID: 25547678.
      View in: PubMed
    159. Berindan-Neagoe I, Calin GA. Molecular pathways: microRNAs, cancer cells, and microenvironment. Clin Cancer Res. 2014 Dec 15; 20(24):6247-53. PMID: 25512634.
      View in: PubMed
    160. Tudor S, Giza DE, Lin HY, Fabris L, Yoshiaki K, D'Abundo L, Toale KM, Shimizu M, Ferracin M, Challagundla KB, Cortez MA, Fuentes-Mattei E, Tulbure D, Gonzalez C, Henderson J, Row M, Rice TW, Ivan C, Negrini M, Fabbri M, Morris JS, Yeung SC, Vasilescu C, Calin GA. Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell Death Dis. 2014 Dec 04; 5:e1559. PMID: 25476907.
      View in: PubMed
    161. Ciccone M, Ferrajoli A, Keating MJ, Calin GA. SnapShot: chronic lymphocytic leukemia. Cancer Cell. 2014 Nov 10; 26(5):770-770.e1. PMID: 25517752.
      View in: PubMed
    162. Silla T, Kepp K, Tai ES, Goh L, Davila S, Catela Ivkovic T, Calin GA, Voorhoeve PM. Allele frequencies of variants in ultra conserved elements identify selective pressure on transcription factor binding. PLoS One. 2014; 9(11):e110692. PMID: 25369454.
      View in: PubMed
    163. Chen M, Calin GA, Meng QH. Circulating microRNAs as Promising Tumor Biomarkers. Adv Clin Chem. 2014; 67:189-214. PMID: 25735862.
      View in: PubMed
    164. Rupaimoole R, Wu SY, Pradeep S, Ivan C, Pecot CV, Gharpure KM, Nagaraja AS, Armaiz-Pena GN, McGuire M, Zand B, Dalton HJ, Filant J, Miller JB, Lu C, Sadaoui NC, Mangala LS, Taylor M, van den Beucken T, Koch E, Rodriguez-Aguayo C, Huang L, Bar-Eli M, Wouters BG, Radovich M, Ivan M, Calin GA, Zhang W, Lopez-Berestein G, Sood AK. Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun. 2014 Oct 29; 5:5202. PMID: 25351346.
      View in: PubMed
    165. Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, Lucci A, Ivan C, Calin GA, Kalluri R. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. 2014 Nov 10; 26(5):707-21. PMID: 25446899.
      View in: PubMed
    166. Sato-Kuwabara Y, Melo SA, Soares FA, Calin GA. The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). Int J Oncol. 2015 Jan; 46(1):17-27. PMID: 25338714.
      View in: PubMed
    167. Zhang S, Lu Z, Unruh AK, Ivan C, Baggerly KA, Calin GA, Li Z, Bast RC, Le XF. Clinically relevant microRNAs in ovarian cancer. Mol Cancer Res. 2015 Mar; 13(3):393-401. PMID: 25304686.
      View in: PubMed
    168. Galasso M, Dama P, Previati M, Sandhu S, Palatini J, Coppola V, Warner S, Sana ME, Zanella R, Abujarour R, Desponts C, Teitell MA, Garzon R, Calin G, Croce CM, Volinia S. A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. Genome Med. 2014; 6(10):76. PMID: 25352916.
      View in: PubMed
    169. Giza DE, Vasilescu C, Calin GA. Key principles of miRNA involvement in human diseases. Discoveries (Craiova). 2014 Oct-Dec; 2(4):e34. PMID: 26317116.
      View in: PubMed
    170. Ress AL, Stiegelbauer V, Schwarzenbacher D, Deutsch A, Perakis S, Ling H, Ivan C, Calin GA, Rinner B, Gerger A, Pichler M. Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer. Oncotarget. 2014 Sep 30; 5(18):8492-502. PMID: 25261368.
      View in: PubMed
    171. Braicu C, Tomuleasa C, Monroig P, Cucuianu A, Berindan-Neagoe I, Calin GA. Exosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell Death Differ. 2015 Jan; 22(1):34-45. PMID: 25236394.
      View in: PubMed
    172. Nassar FJ, El Sabban M, Zgheib NK, Tfayli A, Boulos F, Jabbour M, El Saghir NS, Talhouk R, Bazarbachi A, Calin GA, Nasr R. miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study. PLoS One. 2014; 9(9):e107566. PMID: 25232827.
      View in: PubMed
    173. Monroig Pdel C, Chen L, Zhang S, Calin GA. Small molecule compounds targeting miRNAs for cancer therapy. Adv Drug Deliv Rev. 2015 Jan; 81:104-16. PMID: 25239236.
      View in: PubMed
    174. Zuo Z, Maiti S, Hu S, Loghavi S, Calin GA, Garcia-Manero G, Kantarjian HM, Medeiros LJ, Cooper LJ, Bueso-Ramos CE. Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes. Mod Pathol. 2015 Mar; 28(3):373-82. PMID: 25216221.
      View in: PubMed
    175. Bottai G, Pasculli B, Calin GA, Santarpia L. Targeting the microRNA-regulating DNA damage/repair pathways in cancer. Expert Opin Biol Ther. 2014 Nov; 14(11):1667-83. PMID: 25190496.
      View in: PubMed
    176. Kunej T, Obsteter J, Pogacar Z, Horvat S, Calin GA. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring. Crit Rev Clin Lab Sci. 2014 Dec; 51(6):344-57. PMID: 25123609.
      View in: PubMed
    177. Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014 Sep-Oct; 64(5):311-36. PMID: 25104502.
      View in: PubMed
    178. Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R, Mahaffey S, Rossi S, Calin GA, Bemis L, Theodorescu D. The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res. 2014; 42(17):e133. PMID: 25063298.
      View in: PubMed
    179. Xu S, Wei J, Wang F, Kong LY, Ling XY, Nduom E, Gabrusiewicz K, Doucette T, Yang Y, Yaghi NK, Fajt V, Levine JM, Qiao W, Li XG, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst. 2014 Aug; 106(8). PMID: 24974128.
      View in: PubMed
    180. Giza DE, Vasilescu C, Calin GA. MicroRNAs and ceRNAs: therapeutic implications of RNA networks. Expert Opin Biol Ther. 2014 Sep; 14(9):1285-93. PMID: 24941322.
      View in: PubMed
    181. Wu SY, Lopez-Berestein G, Calin GA, Sood AK. RNAi therapies: drugging the undruggable. Sci Transl Med. 2014 Jun 11; 6(240):240ps7. PMID: 24920658.
      View in: PubMed
    182. Negrini M, Cutrona G, Bassi C, Fabris S, Zagatti B, Colombo M, Ferracin M, D'Abundo L, Saccenti E, Matis S, Lionetti M, Agnelli L, Gentile M, Recchia AG, Bossio S, Reverberi D, Rigolin G, Calin GA, Sabbioni S, Russo G, Tassone P, Morabito F, Ferrarini M, Neri A. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters. Clin Cancer Res. 2014 Aug 01; 20(15):4141-53. PMID: 24916701.
      View in: PubMed
    183. Kita Y, Vincent K, Natsugoe S, Berindan-Neagoe I, Calin GA. Epigenetically regulated microRNAs and their prospect in cancer diagnosis. Expert Rev Mol Diagn. 2014 Jul; 14(6):673-83. PMID: 24914586.
      View in: PubMed
    184. Cui B, Chen L, Zhang S, Mraz M, Fecteau JF, Yu J, Ghia EM, Zhang L, Bao L, Rassenti LZ, Messer K, Calin GA, Croce CM, Kipps TJ. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood. 2014 Jul 24; 124(4):546-54. PMID: 24914134.
      View in: PubMed
    185. Pichler M, Calin GA. Long noncoding RNA in neuroblastoma: new light on the (old) N-Myc story. J Natl Cancer Inst. 2014 Jul; 106(7). PMID: 24906400.
      View in: PubMed
    186. Liz J, Portela A, Soler M, Gómez A, Ling H, Michlewski G, Calin GA, Guil S, Esteller M. Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region. Mol Cell. 2014 Jul 03; 55(1):138-47. PMID: 24910097.
      View in: PubMed
    187. Ruvolo PP, Ruvolo VR, Jacamo R, Burks JK, Zeng Z, Duvvuri SR, Zhou L, Qiu Y, Coombes KR, Zhang N, Yoo SY, Pan R, Hail N, Konopleva M, Calin G, Kornblau SM, Andreeff M. The protein phosphatase 2A regulatory subunit B55a is a modulator of signaling and microRNA expression in acute myeloid leukemia cells. Biochim Biophys Acta. 2014 Sep; 1843(9):1969-77. PMID: 24858343.
      View in: PubMed
    188. Cortez MA, Valdecanas D, Zhang X, Zhan Y, Bhardwaj V, Calin GA, Komaki R, Giri DK, Quini CC, Wolfe T, Peltier HJ, Bader AG, Heymach JV, Meyn RE, Welsh JW. Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. Mol Ther. 2014 Aug; 22(8):1494-1503. PMID: 24791940.
      View in: PubMed
    189. Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, Nykter M, Shmulevich I, Fuller GN, Lang FF, Zhang W. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015 Mar 26; 34(13):1619-1628. PMID: 24747968.
      View in: PubMed
    190. Liu X, Robinson SN, Setoyama T, Tung SS, D'Abundo L, Shah MY, Yang H, Yvon E, Shah N, Yang H, Konopleva M, Garcia-Manero G, McNiece I, Rezvani K, Calin GA, Shpall EJ, Parmar S. FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells. Bone Marrow Transplant. 2014 Jun; 49(6):793-9. PMID: 24710569.
      View in: PubMed
    191. Gañán-Gómez I, Wei Y, Yang H, Pierce S, Bueso-Ramos C, Calin G, Boyano-Adánez Mdel C, García-Manero G. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-?B activation and enhances erythroid differentiation arrest. PLoS One. 2014; 9(4):e93404. PMID: 24690917.
      View in: PubMed
    192. Shah MY, Calin GA. MicroRNAs as therapeutic targets in human cancers. Wiley Interdiscip Rev RNA. 2014 Jul-Aug; 5(4):537-48. PMID: 24687772.
      View in: PubMed
    193. Armenia J, Fabris L, Lovat F, Berton S, Segatto I, D'Andrea S, Ivan C, Cascione L, Calin GA, Croce CM, Colombatti A, Vecchione A, Belletti B, Baldassarre G. Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner. Oncotarget. 2014 Mar 15; 5(5):1185-97. PMID: 24727437.
      View in: PubMed
    194. Ferreira AF, Moura LG, Tojal I, Ambrósio L, Pinto-Simões B, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells Mol Dis. 2014 Jun-Aug; 53(1-2):47-55. PMID: 24629639.
      View in: PubMed
    195. Pichler M, Ress AL, Winter E, Stiegelbauer V, Karbiener M, Schwarzenbacher D, Scheideler M, Ivan C, Jahn SW, Kiesslich T, Gerger A, Bauernhofer T, Calin GA, Hoefler G. MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Br J Cancer. 2014 Mar 18; 110(6):1614-21. PMID: 24504363.
      View in: PubMed
    196. Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014 Mar; 11(3):145-56. PMID: 24492836.
      View in: PubMed
    197. Crippa E, Lusa L, De Cecco L, Marchesi E, Calin GA, Radice P, Manoukian S, Peissel B, Daidone MG, Gariboldi M, Pierotti MA. miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer. PLoS One. 2014; 9(1):e87039. PMID: 24475217.
      View in: PubMed
    198. Anfossi S, Giordano A, Gao H, Cohen EN, Tin S, Wu Q, Garza RJ, Debeb BG, Alvarez RH, Valero V, Hortobagyi GN, Calin GA, Ueno NT, Woodward WA, Reuben JM. High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer. PLoS One. 2014; 9(1):e83113. PMID: 24416156.
      View in: PubMed
    199. Bottoni A, Calin GA. MicroRNAs as main players in the pathogenesis of chronic lymphocytic leukemia. Microrna. 2014; 2(3):158-64. PMID: 25069439.
      View in: PubMed
    200. Braicu C, Catana C, Calin GA, Berindan-Neagoe I. NCRNA combined therapy as future treatment option for cancer. Curr Pharm Des. 2014; 20(42):6565-74. PMID: 25341933.
      View in: PubMed
    201. Wang LQ, Kwong YL, Kho CS, Wong KF, Wong KY, Ferracin M, Calin GA, Chim CS. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NF?B pathway. Mol Cancer. 2013 Dec 27; 12:173. PMID: 24373626.
      View in: PubMed
    202. Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2014 Jun; 65(6):1140-51. PMID: 24373479.
      View in: PubMed
    203. Gee HE, Ivan C, Calin GA, Ivan M. HypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal. 2014 Sep 10; 21(8):1220-38. PMID: 24111776.
      View in: PubMed
    204. Rayner K, Dimmeler S, Calin GA, Thum T, Raizman JE, Diamandis EP. Novel biomarkers for acute myocardial infarction: is microRNA the new kid on the block? Clin Chem. 2014 Jun; 60(6):812-7. PMID: 24212084.
      View in: PubMed
    205. Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013 Nov; 12(11):847-65. PMID: 24172333.
      View in: PubMed
    206. Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RF. A miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocr Relat Cancer. 2013 Dec; 20(6):809-23. PMID: 24127332.
      View in: PubMed
    207. Maia BM, Rocha RM, Calin GA. Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology. Epigenetics. 2014 Jan; 9(1):75-80. PMID: 24121593.
      View in: PubMed
    208. Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, Ye X, Lu J, Fan F, Xia L, Calin GA, Ellis LM, Lu X. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Mol Oncol. 2014 Feb; 8(1):83-92. PMID: 24145123.
      View in: PubMed
    209. Wan G, Hu X, Liu Y, Han C, Sood AK, Calin GA, Zhang X, Lu X. A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation. EMBO J. 2013 Oct 30; 32(21):2833-47. PMID: 24097061.
      View in: PubMed
    210. Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, Buiga R, Pop V, Irimie A, Fodde R, Bedrosian I, Martens JW, Foekens JA, Berindan-Neagoe I, Calin GA. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget. 2013 Oct; 4(10):1748-62. PMID: 24077681.
      View in: PubMed
    211. Vasilescu C, Olteanu M, Flondor P, Calin GA. Fractal-like kinetics of intracellular enzymatic reactions: a chemical framework of endotoxin tolerance and a possible non-specific contribution of macromolecular crowding to cross-tolerance. Theor Biol Med Model. 2013 Sep 14; 10:55. PMID: 24034421.
      View in: PubMed
    212. Ferdin J, Nishida N, Wu X, Nicoloso MS, Shah MY, Devlin C, Ling H, Shimizu M, Kumar K, Cortez MA, Ferracin M, Bi Y, Yang D, Czerniak B, Zhang W, Schmittgen TD, Voorhoeve MP, Reginato MJ, Negrini M, Davuluri RV, Kunej T, Ivan M, Calin GA. HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. Cell Death Differ. 2013 Dec; 20(12):1675-87. PMID: 24037088.
      View in: PubMed
    213. Nouraee N, Van Roosbroeck K, Vasei M, Semnani S, Samaei NM, Naghshvar F, Omidi AA, Calin GA, Mowla SJ. Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma. PLoS One. 2013; 8(9):e73009. PMID: 24039846.
      View in: PubMed
    214. Manyam G, Ivan C, Calin GA, Coombes KR. targetHub: a programmable interface for miRNA-gene interactions. Bioinformatics. 2013 Oct 15; 29(20):2657-8. PMID: 24013925.
      View in: PubMed
    215. Nishimura M, Jung EJ, Shah MY, Lu C, Spizzo R, Shimizu M, Han HD, Ivan C, Rossi S, Zhang X, Nicoloso MS, Wu SY, Almeida MI, Bottsford-Miller J, Pecot CV, Zand B, Matsuo K, Shahzad MM, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Calin GA. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov. 2013 Nov; 3(11):1302-15. PMID: 24002999.
      View in: PubMed
    216. Wu X, Bhayani MK, Dodge CT, Nicoloso MS, Chen Y, Yan X, Adachi M, Thomas L, Galer CE, Jiffar T, Pickering CR, Kupferman ME, Myers JN, Calin GA, Lai SY. Coordinated targeting of the EGFR signaling axis by microRNA-27a*. Oncotarget. 2013 Sep; 4(9):1388-98. PMID: 23963114.
      View in: PubMed
    217. Gumireddy K, Li A, Yan J, Setoyama T, Johannes GJ, Orom UA, Tchou J, Liu Q, Zhang L, Speicher DW, Calin GA, Huang Q. Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. EMBO J. 2013 Oct 16; 32(20):2672-84. PMID: 23974796.
      View in: PubMed
    218. Nishida N, Mimori K, Mori M, Calin GA. EGFR gets in the way of microRNA biogenesis. Cell Res. 2013 Oct; 23(10):1157-8. PMID: 23835474.
      View in: PubMed
    219. Ferrajoli A, Shanafelt TD, Ivan C, Shimizu M, Rabe KG, Nouraee N, Ikuo M, Ghosh AK, Lerner S, Rassenti LZ, Xiao L, Hu J, Reuben JM, Calin S, You MJ, Manning JT, Wierda WG, Estrov Z, O'Brien S, Kipps TJ, Keating MJ, Kay NE, Calin GA. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood. 2013 Sep 12; 122(11):1891-9. PMID: 23821659.
      View in: PubMed
    220. Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, Ivan C, Barbarotto E, De Vries I, Zhang X, Ferracin M, Churchman M, van Galen JF, Beverloo BH, Shariati M, Haderk F, Estecio MR, Garcia-Manero G, Patijn GA, Gotley DC, Bhardwaj V, Shureiqi I, Sen S, Multani AS, Welsh J, Yamamoto K, Taniguchi I, Song MA, Gallinger S, Casey G, Thibodeau SN, Le Marchand L, Tiirikainen M, Mani SA, Zhang W, Davuluri RV, Mimori K, Mori M, Sieuwerts AM, Martens JW, Tomlinson I, Negrini M, Berindan-Neagoe I, Foekens JA, Hamilton SR, Lanza G, Kopetz S, Fodde R, Calin GA. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013 Sep; 23(9):1446-61. PMID: 23796952.
      View in: PubMed
    221. Godnic I, Zorc M, Jevsinek Skok D, Calin GA, Horvat S, Dovc P, Kovac M, Kunej T. Genome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chicken. PLoS One. 2013; 8(6):e65165. PMID: 23762306.
      View in: PubMed
    222. Li P, Grgurevic S, Liu Z, Harris D, Rozovski U, Calin GA, Keating MJ, Estrov Z. Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia. PLoS One. 2013; 8(6):e64678. PMID: 23750211.
      View in: PubMed
    223. Rozovski U, Calin GA, Setoyama T, D'Abundo L, Harris DM, Li P, Liu Z, Grgurevic S, Ferrajoli A, Faderl S, Burger JA, O'Brien S, Wierda WG, Keating MJ, Estrov Z. Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells. Mol Cancer. 2013 Jun 01; 12:50. PMID: 23725032.
      View in: PubMed
    224. Atlasi Y, Noori R, Gaspar C, Franken P, Sacchetti A, Rafati H, Mahmoudi T, Decraene C, Calin GA, Merrill BJ, Fodde R. Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation. PLoS Genet. 2013 May; 9(5):e1003424. PMID: 23658527.
      View in: PubMed
    225. Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013 Jul 01; 73(13):3913-26. PMID: 23636127.
      View in: PubMed
    226. Van Roosbroeck K, Pollet J, Calin GA. miRNAs and long noncoding RNAs as biomarkers in human diseases. Expert Rev Mol Diagn. 2013 Mar; 13(2):183-204. PMID: 23477558.
      View in: PubMed
    227. Monroig PD, Calin GA. MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities. Curr Pathobiol Rep. 2013 Mar; 1(1):43-52. PMID: 23515489.
      View in: PubMed
    228. Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K, Stephens RM, Calin GA, Croce CM, Ambs S. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer. 2013 Feb 14; 12:13. PMID: 23409773.
      View in: PubMed
    229. Jin L, Wessely O, Marcusson EG, Ivan C, Calin GA, Alahari SK. Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-a in breast cancer. Cancer Res. 2013 May 01; 73(9):2884-96. PMID: 23338610.
      View in: PubMed
    230. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, Bottsford-Miller J, Liu Y, Kim SB, Unruh A, Gonzalez-Villasana V, Huang L, Zand B, Moreno-Smith M, Mangala LS, Taylor M, Dalton HJ, Sehgal V, Wen Y, Kang Y, Baggerly KA, Lee JS, Ram PT, Ravoori MK, Kundra V, Zhang X, Ali-Fehmi R, Gonzalez-Angulo AM, Massion PP, Calin GA, Lopez-Berestein G, Zhang W, Sood AK. Tumour angiogenesis regulation by the miR-200 family. Nat Commun. 2013; 4:2427. PMID: 24018975.
      View in: PubMed
    231. Rossi S, Calin GA. Bioinformatics, non-coding RNAs and its possible application in personalized medicine. Adv Exp Med Biol. 2013; 774:21-37. PMID: 23377966.
      View in: PubMed
    232. Fabbri M, Calore F, Paone A, Galli R, Calin GA. Epigenetic regulation of miRNAs in cancer. Adv Exp Med Biol. 2013; 754:137-48. PMID: 22956499.
      View in: PubMed
    233. Taube JH, Malouf GG, Lu E, Sphyris N, Vijay V, Ramachandran PP, Ueno KR, Gaur S, Nicoloso MS, Rossi S, Herschkowitz JI, Rosen JM, Issa JP, Calin GA, Chang JT, Mani SA. Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties. Sci Rep. 2013; 3:2687. PMID: 24045437.
      View in: PubMed
    234. Braicu C, Calin GA, Berindan-Neagoe I. MicroRNAs and cancer therapy - from bystanders to major players. Curr Med Chem. 2013; 20(29):3561-73. PMID: 23834177.
      View in: PubMed
    235. Nouraee N, Calin GA. MicroRNAs as cancer biomarkers. Microrna. 2013; 2(2):102-17. PMID: 25070780.
      View in: PubMed
    236. Shah MY, Calin GA. The mix of two worlds: non-coding RNAs and hormones. Nucleic Acid Ther. 2013 Feb; 23(1):2-8. PMID: 23051203.
      View in: PubMed
    237. Chen L, Calin GA, Zhang S. Novel insights of structure-based modeling for RNA-targeted drug discovery. J Chem Inf Model. 2012 Oct 22; 52(10):2741-53. PMID: 22947071.
      View in: PubMed
    238. Tsongalis GJ, Calin G, Cordelier P, Croce C, Monzon F, Szafranska-Schwarzbach AE. MicroRNA analysis: is it ready for prime time? Clin Chem. 2013 Feb; 59(2):343-7. PMID: 22935643.
      View in: PubMed
    239. Redis RS, Calin S, Yang Y, You MJ, Calin GA. Cell-to-cell miRNA transfer: from body homeostasis to therapy. Pharmacol Ther. 2012 Nov; 136(2):169-74. PMID: 22903157.
      View in: PubMed
    240. Le XF, Almeida MI, Mao W, Spizzo R, Rossi S, Nicoloso MS, Zhang S, Wu Y, Calin GA, Bast RC. Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer. PLoS One. 2012; 7(7):e41170. PMID: 22829924.
      View in: PubMed
    241. Calin GA, Konopleva M. Small gene, big number, many effects. Blood. 2012 Jul 12; 120(2):240-1. PMID: 22791772.
      View in: PubMed
    242. Almeida MI, Reis RM, Calin GA. Decoy activity through microRNAs: the therapeutic implications. Expert Opin Biol Ther. 2012 Sep; 12(9):1153-9. PMID: 22650365.
      View in: PubMed
    243. Lin M, Gu J, Eng C, Ellis LM, Hildebrandt MA, Lin J, Huang M, Calin GA, Wang D, Dubois RN, Hawk ET, Wu X. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res. 2012 Jul 15; 18(14):3982-91. PMID: 22661538.
      View in: PubMed
    244. Redis RS, Berindan-Neagoe I, Pop VI, Calin GA. Non-coding RNAs as theranostics in human cancers. J Cell Biochem. 2012 May; 113(5):1451-9. PMID: 22213511.
      View in: PubMed
    245. Kunej T, Godnic I, Horvat S, Zorc M, Calin GA. Cross talk between microRNA and coding cancer genes. Cancer J. 2012 May-Jun; 18(3):223-31. PMID: 22647358.
      View in: PubMed
    246. Zhang P, Bill K, Liu J, Young E, Peng T, Bolshakov S, Hoffman A, Song Y, Demicco EG, Terrada DL, Creighton CJ, Anderson ML, Lazar AJ, Calin GG, Pollock RE, Lev D. MiR-155 is a liposarcoma oncogene that targets casein kinase-1a and enhances ß-catenin signaling. Cancer Res. 2012 Apr 01; 72(7):1751-62. PMID: 22350414.
      View in: PubMed
    247. Zorc M, Skok DJ, Godnic I, Calin GA, Horvat S, Jiang Z, Dovc P, Kunej T. Catalog of microRNA seed polymorphisms in vertebrates. PLoS One. 2012; 7(1):e30737. PMID: 22303453.
      View in: PubMed
    248. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012 Oct 25; 31(43):4577-87. PMID: 22266873.
      View in: PubMed
    249. Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology. 2012 Apr; 142(4):886-896.e9. PMID: 22240480.
      View in: PubMed
    250. Rivetti di Val Cervo P, Lena AM, Nicoloso M, Rossi S, Mancini M, Zhou H, Saintigny G, Dellambra E, Odorisio T, Mahé C, Calin GA, Candi E, Melino G. p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci U S A. 2012 Jan 24; 109(4):1133-8. PMID: 22228303.
      View in: PubMed
    251. Cortez MA, Welsh JW, Calin GA. Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res. 2012; 195:151-61. PMID: 22527502.
      View in: PubMed
    252. Ferracin M, Querzoli P, Calin GA, Negrini M. MicroRNAs: toward the clinic for breast cancer patients. Semin Oncol. 2011 Dec; 38(6):764-75. PMID: 22082762.
      View in: PubMed
    253. Olaru AV, Ghiaur G, Yamanaka S, Luvsanjav D, An F, Popescu I, Alexandrescu S, Allen S, Pawlik TM, Torbenson M, Georgiades C, Roberts LR, Gores GJ, Ferguson-Smith A, Almeida MI, Calin GA, Mezey E, Selaru FM. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology. 2011 Dec; 54(6):2089-98. PMID: 21809359.
      View in: PubMed
    254. Bhayani MK, Calin GA, Lai SY. Functional relevance of miRNA sequences in human disease. Mutat Res. 2012 Mar 01; 731(1-2):14-9. PMID: 22085809.
      View in: PubMed
    255. Ling H, Zhang W, Calin GA. Principles of microRNA involvement in human cancers. Chin J Cancer. 2011 Nov; 30(11):739-48. PMID: 22035854.
      View in: PubMed
    256. Jung EJ, Santarpia L, Kim J, Esteva FJ, Moretti E, Buzdar AU, Di Leo A, Le XF, Bast RC, Park ST, Pusztai L, Calin GA. Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer. 2012 May 15; 118(10):2603-14. PMID: 22370716.
      View in: PubMed
    257. Bartley AN, Yao H, Barkoh BA, Ivan C, Mishra BM, Rashid A, Calin GA, Luthra R, Hamilton SR. Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer. Clin Cancer Res. 2011 Dec 01; 17(23):7283-93. PMID: 21948089.
      View in: PubMed
    258. Shah MY, Calin GA. MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med. 2011 Aug 31; 3(8):56. PMID: 21888691.
      View in: PubMed
    259. Setoyama T, Zhang X, Natsugoe S, Calin GA. microRNA-10b: a new marker or the marker of pancreatic ductal adenocarcinoma? Clin Cancer Res. 2011 Sep 01; 17(17):5527-9. PMID: 21816909.
      View in: PubMed
    260. Munker R, Calin GA. MicroRNA profiling in cancer. Clin Sci (Lond). 2011 Aug; 121(4):141-58. PMID: 21526983.
      View in: PubMed
    261. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011 Jun 07; 8(8):467-77. PMID: 21647195.
      View in: PubMed
    262. Zuo Z, Calin GA, de Paula HM, Medeiros LJ, Fernandez MH, Shimizu M, Garcia-Manero G, Bueso-Ramos CE. Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome. Blood. 2011 Jul 14; 118(2):413-5. PMID: 21602527.
      View in: PubMed
    263. Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. 2011 Dec 01; 717(1-2):1-8. PMID: 21458467.
      View in: PubMed
    264. Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, Calin GA. Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat Res. 2011 Dec 01; 717(1-2):77-84. PMID: 21420983.
      View in: PubMed
    265. Lee SK, Calin GA. Non-coding RNAs and cancer: new paradigms in oncology. Discov Med. 2011 Mar; 11(58):245-54. PMID: 21447283.
      View in: PubMed
    266. Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, Rossi S, Setien F, Casanovas O, Simo-Riudalbas L, Carmona J, Carrere J, Vidal A, Aytes A, Puertas S, Ropero S, Kalluri R, Croce CM, Calin GA, Esteller M. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A. 2011 Mar 15; 108(11):4394-9. PMID: 21368194.
      View in: PubMed
    267. Zheng H, Song F, Zhang L, Yang D, Ji P, Wang Y, Almeida M, Calin GA, Hao X, Wei Q, Zhang W, Chen K. Genetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer. Int J Oncol. 2011 Apr; 38(4):1153-61. PMID: 21318219.
      View in: PubMed
    268. Almeida MI, Reis RM, Calin GA. BRCA1, microRNAs and cancer predisposition: challenging the dogma. Cell Cycle. 2011 Feb 01; 10(3):377. PMID: 21270524.
      View in: PubMed
    269. Yang H, Fang Z, Wei Y, Hu Y, Calin GA, Kantarjian HM, Garcia-Manero G. Levels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-azacytidine, valproic acid, and ATRA. Am J Hematol. 2011 Feb; 86(2):237-8. PMID: 21264920.
      View in: PubMed
    270. Shao M, Rossi S, Chelladurai B, Shimizu M, Ntukogu O, Ivan M, Calin GA, Matei D. PDGF induced microRNA alterations in cancer cells. Nucleic Acids Res. 2011 May; 39(10):4035-47. PMID: 21266476.
      View in: PubMed
    271. Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, Valeri N, Calore F, Sampath D, Fanini F, Vannini I, Musuraca G, Dell'Aquila M, Alder H, Davuluri RV, Rassenti LZ, Negrini M, Nakamura T, Amadori D, Kay NE, Rai KR, Keating MJ, Kipps TJ, Calin GA, Croce CM. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA. 2011 Jan 05; 305(1):59-67. PMID: 21205967.
      View in: PubMed
    272. Ferdin J, Kunej T, Calin GA. MicroRNA: Genomic Association with Cancer Predisposition. J Assoc Genet Technol. 2011; 37(1):11-9. PMID: 21430351.
      View in: PubMed
    273. Setoyama T, Ling H, Natsugoe S, Calin GA. Non-coding RNAs for medical practice in oncology. Keio J Med. 2011; 60(4):106-13. PMID: 22200634.
      View in: PubMed
    274. Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK. RNA interference in the clinic: challenges and future directions. Nat Rev Cancer. 2011 Jan; 11(1):59-67. PMID: 21160526.
      View in: PubMed
    275. Wang Y, Scheiber MN, Neumann C, Calin GA, Zhou D. MicroRNA regulation of ionizing radiation-induced premature senescence. Int J Radiat Oncol Biol Phys. 2011 Nov 01; 81(3):839-48. PMID: 21093163.
      View in: PubMed
    276. Cortez MA, Nicoloso MS, Shimizu M, Rossi S, Gopisetty G, Molina JR, Carlotti C, Tirapelli D, Neder L, Brassesco MS, Scrideli CA, Tone LG, Georgescu MM, Zhang W, Puduvalli V, Calin GA. miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes Chromosomes Cancer. 2010 Nov; 49(11):981-90. PMID: 20665731.
      View in: PubMed
    277. Iuliano R, Palmieri D, He H, Iervolino A, Borbone E, Pallante P, Cianflone A, Nagy R, Alder H, Calin GA, Trapasso F, Giordano C, Croce CM, de la Chapelle A, Fusco A. Role of PTPRJ genotype in papillary thyroid carcinoma risk. Endocr Relat Cancer. 2010 Dec; 17(4):1001-6. PMID: 20823296.
      View in: PubMed
    278. Rossi S, Tsirigos A, Amoroso A, Mascellani N, Rigoutsos I, Calin GA, Volinia S. OMiR: Identification of associations between OMIM diseases and microRNAs. Genomics. 2011 Feb; 97(2):71-6. PMID: 20974243.
      View in: PubMed
    279. Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, Fernandez AF, Davalos V, Villanueva A, Montoya G, Yamamoto H, Schwartz S, Esteller M. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell. 2010 Oct 19; 18(4):303-15. PMID: 20951941.
      View in: PubMed
    280. Lee SK, Calin GA. Genetic control of mammalian T-cell proliferation with a synthetic RNA regulatory system - illusion or reality? Genome Med. 2010 Oct 15; 2(10):77. PMID: 20959026.
      View in: PubMed
    281. Urdinguio RG, Fernandez AF, Lopez-Nieva P, Rossi S, Huertas D, Kulis M, Liu CG, Croce CM, Calin GA, Esteller M. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics. 2010 Oct 01; 5(7):656-63. PMID: 20716963.
      View in: PubMed
    282. Jung EJ, Calin GA. The Meaning of 21 in the MicroRNA world: perfection rather than destruction? Cancer Cell. 2010 Sep 14; 18(3):203-5. PMID: 20832748.
      View in: PubMed
    283. Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene. 2010 Dec 02; 29(48):6390-401. PMID: 20802525.
      View in: PubMed
    284. Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, Ravoori MK, Shahzad MM, Lee JW, Mora E, Langley RR, Carroll AR, Matsuo K, Spannuth WA, Schmandt R, Jennings NB, Goodman BW, Jaffe RB, Nick AM, Kim HS, Guven EO, Chen YH, Li LY, Hsu MC, Coleman RL, Calin GA, Denkbas EB, Lim JY, Lee JS, Kundra V, Birrer MJ, Hung MC, Lopez-Berestein G, Sood AK. Regulation of tumor angiogenesis by EZH2. Cancer Cell. 2010 Aug 09; 18(2):185-97. PMID: 20708159.
      View in: PubMed
    285. Tili E, Michaille JJ, Liu CG, Alder H, Taccioli C, Volinia S, Calin GA, Croce CM. GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials. Nucleic Acids Res. 2010 Nov; 38(21):7673-88. PMID: 20639536.
      View in: PubMed
    286. Felli N, Cianetti L, Pelosi E, Carè A, Liu CG, Calin GA, Rossi S, Peschle C, Marziali G, Giuliani A. Hematopoietic differentiation: a coordinated dynamical process towards attractor stable states. BMC Syst Biol. 2010 Jun 16; 4:85. PMID: 20553595.
      View in: PubMed
    287. Almeida MI, Reis RM, Calin GA. MYC-microRNA-9-metastasis connection in breast cancer. Cell Res. 2010 Jun; 20(6):603-4. PMID: 20502442.
      View in: PubMed
    288. Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2010 Jun 15; 70(12):5184-93. PMID: 20501828.
      View in: PubMed
    289. Sampath D, Calin GA. Coding and noncoding: the CLL mix. Blood. 2010 May 13; 115(19):3858-9. PMID: 20466868.
      View in: PubMed
    290. Edwards JK, Pasqualini R, Arap W, Calin GA. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J Cardiovasc Transl Res. 2010 Jun; 3(3):271-9. PMID: 20560048.
      View in: PubMed
    291. Fabbri M, Calin GA. Beyond genomics: interpreting the 93% of the human genome that does not encode proteins. Curr Opin Drug Discov Devel. 2010 May; 13(3):350-8. PMID: 20443168.
      View in: PubMed
    292. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CM. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 2010 May; 20(5):589-99. PMID: 20439436.
      View in: PubMed
    293. Zhang S, Chen L, Jung EJ, Calin GA. Targeting microRNAs with small molecules: from dream to reality. Clin Pharmacol Ther. 2010 Jun; 87(6):754-8. PMID: 20428111.
      View in: PubMed
    294. Rossi S, Shimizu M, Barbarotto E, Nicoloso MS, Dimitri F, Sampath D, Fabbri M, Lerner S, Barron LL, Rassenti LZ, Jiang L, Xiao L, Hu J, Secchiero P, Zauli G, Volinia S, Negrini M, Wierda W, Kipps TJ, Plunkett W, Coombes KR, Abruzzo LV, Keating MJ, Calin GA. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood. 2010 Aug 12; 116(6):945-52. PMID: 20393129.
      View in: PubMed
    295. Ferdin J, Kunej T, Calin GA. Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling. Technol Cancer Res Treat. 2010 Apr; 9(2):123-38. PMID: 20218735.
      View in: PubMed
    296. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010 Apr 01; 70(7):2789-98. PMID: 20332227.
      View in: PubMed
    297. Almeida MI, Reis RM, Calin GA. MicroRNAs and metastases--the neuroblastoma link. Cancer Biol Ther. 2010 Mar 15; 9(6):453-4. PMID: 20139721.
      View in: PubMed
    298. Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R, Liu S, Schwind S, Santhanam R, Hickey CJ, Becker H, Chandler JC, Andino R, Cortes J, Hokland P, Huettner CS, Bhatia R, Roy DC, Liebhaber SA, Caligiuri MA, Marcucci G, Garzon R, Croce CM, Calin GA, Perrotti D. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell. 2010 Mar 05; 140(5):652-65. PMID: 20211135.
      View in: PubMed
    299. Le XF, Merchant O, Bast RC, Calin GA. The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenviron. 2010 Feb 23; 3(1):137-47. PMID: 21209780.
      View in: PubMed
    300. Santarpia L, Nicoloso M, Calin GA. MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype. Endocr Relat Cancer. 2010 Mar; 17(1):F51-75. PMID: 19843580.
      View in: PubMed
    301. Fabbri M, Calin GA. Epigenetics and miRNAs in human cancer. Adv Genet. 2010; 70:87-99. PMID: 20920746.
      View in: PubMed
    302. Stanescu L, Vâlcea A, Popescu CF, Niculescu CE, Ciobanu O, Calin G. Plaque-type morphea in children. Rom J Morphol Embryol. 2010; 51(3):559-63. PMID: 20809038.
      View in: PubMed
    303. Fabbri M, Spizzo R, Calin GA. High-throughput profiling in the hematopoietic system. Methods Mol Biol. 2010; 667:79-91. PMID: 20827528.
      View in: PubMed
    304. Cortez MA, Ivan C, Zhou P, Wu X, Ivan M, Calin GA. microRNAs in cancer: from bench to bedside. Adv Cancer Res. 2010; 108:113-57. PMID: 21034967.
      View in: PubMed
    305. Izzotti A, Calin GA, Steele VE, Cartiglia C, Longobardi M, Croce CM, De Flora S. Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs. Cancer Prev Res (Phila). 2010 Jan; 3(1):62-72. PMID: 20051373.
      View in: PubMed
    306. Nicoloso MS, Jasra B, Calin GA. MicroRNAs: new players in AML pathogenesis. Cancer Treat Res. 2010; 145:169-81. PMID: 20306251.
      View in: PubMed
    307. Zanesi N, Pekarsky Y, Trapasso F, Calin G, Croce CM. MicroRNAs in mouse models of lymphoid malignancies. J Nucleic Acids Investig. 2010; 1(1):36-40. PMID: 21666870.
      View in: PubMed
    308. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CM. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010 Feb; 11(2):136-46. PMID: 20022810.
      View in: PubMed
    309. Wojcik SE, Rossi S, Shimizu M, Nicoloso MS, Cimmino A, Alder H, Herlea V, Rassenti LZ, Rai KR, Kipps TJ, Keating MJ, Croce CM, Calin GA. Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis. 2010 Feb; 31(2):208-15. PMID: 19926640.
      View in: PubMed
    310. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA, Mukherjee P. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009 Dec 01; 69(23):9090-5. PMID: 19903841.
      View in: PubMed
    311. Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM. MicroRNA 29b functions in acute myeloid leukemia. Blood. 2009 Dec 17; 114(26):5331-41. PMID: 19850741.
      View in: PubMed
    312. Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, Kulshreshtha R, Banfi C, Stubbs A, Calin GA, Ivan M, Capogrossi MC, Martelli F. An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem. 2009 Dec 11; 284(50):35134-43. PMID: 19826008.
      View in: PubMed
    313. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One. 2009 Oct 12; 4(10):e7405. PMID: 19823581.
      View in: PubMed
    314. Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, Calin GA, Hao X, Wei Q, Zhang W, Chen K. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res. 2009 Oct 01; 15(19):6292-300. PMID: 19789321.
      View in: PubMed
    315. Calin GA, Croce CM. Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. Blood. 2009 Nov 26; 114(23):4761-70. PMID: 19745066.
      View in: PubMed
    316. Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, Davuluri R, Croce CM, Mills G, Negrini M, Calin GA. miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ. 2010 Feb; 17(2):246-54. PMID: 19730444.
      View in: PubMed
    317. Calin GA. MicroRNAs and cancer: what we know and what we still have to learn. Genome Med. 2009 Aug 17; 1(8):78. PMID: 19691821.
      View in: PubMed
    318. Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L, Negrini M. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res. 2009 Aug 15; 15(16):5073-81. PMID: 19671867.
      View in: PubMed
    319. Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M, Dinney C. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res. 2009 Aug 15; 15(16):5060-72. PMID: 19671845.
      View in: PubMed
    320. Naga Prasad SV, Duan ZH, Gupta MK, Surampudi VS, Volinia S, Calin GA, Liu CG, Kotwal A, Moravec CS, Starling RC, Perez DM, Sen S, Wu Q, Plow EF, Croce CM, Karnik S. Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem. 2009 Oct 02; 284(40):27487-99. PMID: 19641226.
      View in: PubMed
    321. Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2009 Jul 15; 69(14):5761-7. PMID: 19584283.
      View in: PubMed
    322. Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 2010 Feb; 17(2):215-20. PMID: 19498445.
      View in: PubMed
    323. Rossi S, Kopetz S, Davuluri R, Hamilton SR, Calin GA. MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol. 2010 Aug; 42(8):1291-7. PMID: 19497386.
      View in: PubMed
    324. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther. 2009 Jun; 9(6):703-711. PMID: 19426115.
      View in: PubMed
    325. Izzotti A, Calin GA, Steele VE, Croce CM, De Flora S. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J. 2009 Sep; 23(9):3243-50. PMID: 19465468.
      View in: PubMed
    326. Sampath D, Calin GA. miRs: fine-tuning prognosis in CLL. Blood. 2009 May 21; 113(21):5035-6. PMID: 19470431.
      View in: PubMed
    327. Negrini M, Nicoloso MS, Calin GA. MicroRNAs and cancer--new paradigms in molecular oncology. Curr Opin Cell Biol. 2009 Jun; 21(3):470-9. PMID: 19411171.
      View in: PubMed
    328. Spizzo R, Nicoloso MS, Croce CM, Calin GA. SnapShot: MicroRNAs in Cancer. Cell. 2009 May 01; 137(3):586-586.e1. PMID: 19410551.
      View in: PubMed
    329. Calin GA. MiR-sensing chemotherapy resistance in CLL. Blood. 2009 Apr 16; 113(16):3652-3. PMID: 19372264.
      View in: PubMed
    330. Ghosh AK, Shanafelt TD, Cimmino A, Taccioli C, Volinia S, Liu CG, Calin GA, Croce CM, Chan DA, Giaccia AJ, Secreto C, Wellik LE, Lee YK, Mukhopadhyay D, Kay NE. Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood. 2009 May 28; 113(22):5568-74. PMID: 19336759.
      View in: PubMed
    331. Fabbri M, Valeri N, Calin GA. MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift. Carcinogenesis. 2009 Jun; 30(6):912-7. PMID: 19293341.
      View in: PubMed
    332. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009 04; 9(4):293-302. PMID: 19262572.
      View in: PubMed
    333. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, Ferreira B, Liu CG, Villanueva A, Capella G, Schwartz S, Shiekhattar R, Esteller M. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet. 2009 Mar; 41(3):365-70. PMID: 19219043.
      View in: PubMed
    334. Fabbri M, Croce CM, Calin GA. MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk Lymphoma. 2009 Feb; 50(2):160-70. PMID: 19160125.
      View in: PubMed
    335. Yendamuri S, Calin GA. The role of microRNA in human leukemia: a review. Leukemia. 2009 Jul; 23(7):1257-63. PMID: 19148134.
      View in: PubMed
    336. Stanescu L, Popescu CF, Georgescu I, Georgescu CV, Anghelina L, Petrescu I, Calin G. Spitz nevus with an uncertain malignant potential. Rom J Morphol Embryol. 2009; 50(2):275-82. PMID: 19434323.
      View in: PubMed
    337. Spizzo R, Rushworth D, Guerrero M, Calin GA. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment. Clin Lymphoma Myeloma. 2009; 9 Suppl 3:S313-8. PMID: 19778859.
      View in: PubMed
    338. Crosby ME, Devlin CM, Glazer PM, Calin GA, Ivan M. Emerging roles of microRNAs in the molecular responses to hypoxia. Curr Pharm Des. 2009; 15(33):3861-6. PMID: 19925433.
      View in: PubMed
    339. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med. 2009; 60:167-79. PMID: 19630570.
      View in: PubMed
    340. Spizzo R, Calin GA. Multiple approach to analyzing the role of microRNAs in apoptosis. Methods Mol Biol. 2009; 559:219-45. PMID: 19609760.
      View in: PubMed
    341. Sampath D, Calin GA, Puduvalli VK, Gopisetty G, Taccioli C, Liu CG, Ewald B, Liu C, Keating MJ, Plunkett W. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood. 2009 Apr 16; 113(16):3744-53. PMID: 19096009.
      View in: PubMed
    342. Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L, Johnstone CN, Chen XM, Liu CG, Huang Q, Katsaros D, Calin GA, Weber BL, Bützow R, Croce CM, Coukos G, Zhang L. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res. 2008 Dec 15; 68(24):10307-14. PMID: 19074899.
      View in: PubMed
    343. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 2009 Mar; 23(3):806-12. PMID: 18952709.
      View in: PubMed
    344. Taccioli C, Fabbri E, Visone R, Volinia S, Calin GA, Fong LY, Gambari R, Bottoni A, Acunzo M, Hagan J, Iorio MV, Piovan C, Romano G, Croce CM. UCbase & miRfunc: a database of ultraconserved sequences and microRNA function. Nucleic Acids Res. 2009 Jan; 37(Database issue):D41-8. PMID: 18945703.
      View in: PubMed
    345. Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller M. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A. 2008 Sep 09; 105(36):13556-61. PMID: 18768788.
      View in: PubMed
    346. Deng S, Calin GA, Croce CM, Coukos G, Zhang L. Mechanisms of microRNA deregulation in human cancer. Cell Cycle. 2008 Sep 01; 7(17):2643-6. PMID: 18719391.
      View in: PubMed
    347. Prueitt RL, Yi M, Hudson RS, Wallace TA, Howe TM, Yfantis HG, Lee DH, Stephens RM, Liu CG, Calin GA, Croce CM, Ambs S. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate. 2008 Aug 01; 68(11):1152-64. PMID: 18459106.
      View in: PubMed
    348. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, Yfantis HG, Stephens RM, Croce CM. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 2008 Aug 01; 68(15):6162-70. PMID: 18676839.
      View in: PubMed
    349. Rossi S, Sevignani C, Nnadi SC, Siracusa LD, Calin GA. Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications. Mamm Genome. 2008 Aug; 19(7-8):526-40. PMID: 18636290.
      View in: PubMed
    350. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene. 2008 Sep 25; 27(43):5651-61. PMID: 18521080.
      View in: PubMed
    351. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell. 2008 Jun; 13(6):496-506. PMID: 18538733.
      View in: PubMed
    352. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis. 2008 Jul; 29(7):1306-11. PMID: 18477647.
      View in: PubMed
    353. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, Bützow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos G. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A. 2008 May 13; 105(19):7004-9. PMID: 18458333.
      View in: PubMed
    354. Barbarotto E, Secchiero P, Dasgupta A, Fortina P, Calin GA, Hyslop T. MicroRNAs as new players in the genomic galaxy and disease puzzles. Clin Transl Sci. 2008 May; 1(1):50-6. PMID: 20443818.
      View in: PubMed
    355. Tili E, Michaille JJ, Calin GA. Expression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci. 2008 Apr 03; 5(2):73-9. PMID: 18392144.
      View in: PubMed
    356. Yendamuri S, Trapasso F, Calin GA. ARLTS1 - a novel tumor suppressor gene. Cancer Lett. 2008 Jun 08; 264(1):11-20. PMID: 18375053.
      View in: PubMed
    357. Negrini M, Calin GA. Breast cancer metastasis: a microRNA story. Breast Cancer Res. 2008; 10(2):203. PMID: 18373886.
      View in: PubMed
    358. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, Alder H, Volinia S, Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M, Croce CM. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A. 2008 Apr 01; 105(13):5166-71. PMID: 18362358.
      View in: PubMed
    359. Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA. MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia. 2008 Jun; 22(6):1095-105. PMID: 18323801.
      View in: PubMed
    360. Barbarotto E, Schmittgen TD, Calin GA. MicroRNAs and cancer: profile, profile, profile. Int J Cancer. 2008 Mar 01; 122(5):969-77. PMID: 18098138.
      View in: PubMed
    361. Spizzo R, Nicoloso MS, Calin GA. MicroRNAs as new biomarkers in oncology. Expert Opin Med Diagn. 2008 Feb; 2(2):115-27. PMID: 23485132.
      View in: PubMed
    362. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008 Jan 30; 299(4):425-36. PMID: 18230780.
      View in: PubMed
    363. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M. A microRNA component of the hypoxic response. Cell Death Differ. 2008 Apr; 15(4):667-71. PMID: 18219318.
      View in: PubMed
    364. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, Flomenberg N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreeff M, Croce CM. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008 Mar 15; 111(6):3183-9. PMID: 18187662.
      View in: PubMed
    365. Barbarotto E, Calin GA. Potential therapeutic applications of miRNA-based technology in hematological malignancies. Curr Pharm Des. 2008; 14(21):2040-50. PMID: 18691114.
      View in: PubMed
    366. Liu CG, Calin GA, Volinia S, Croce CM. MicroRNA expression profiling using microarrays. Nat Protoc. 2008; 3(4):563-78. PMID: 18388938.
      View in: PubMed
    367. Nicoloso MS, Calin GA. MicroRNA involvement in brain tumors: from bench to bedside. Brain Pathol. 2008 Jan; 18(1):122-9. PMID: 18226107.
      View in: PubMed
    368. Fabbri M, Croce CM, Calin GA. MicroRNAs. Cancer J. 2008 Jan-Feb; 14(1):1-6. PMID: 18303474.
      View in: PubMed
    369. Liu CG, Spizzo R, Calin GA, Croce CM. Expression profiling of microRNA using oligo DNA arrays. Methods. 2008 Jan; 44(1):22-30. PMID: 18158129.
      View in: PubMed
    370. Nicoloso MS, Kipps TJ, Croce CM, Calin GA. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia. Br J Haematol. 2007 Dec; 139(5):709-16. PMID: 18021085.
      View in: PubMed
    371. Caporaso N, Goldin L, Plass C, Calin G, Marti G, Bauer S, Raveche E, McMaster ML, Ng D, Landgren O, Slager S. Chronic lymphocytic leukaemia genetics overview. Br J Haematol. 2007 Dec; 139(5):630-4. PMID: 18021078.
      View in: PubMed
    372. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007 Oct 15; 179(8):5082-9. PMID: 17911593.
      View in: PubMed
    373. Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D, Calin GA. miRNAs and their potential for use against cancer and other diseases. Future Oncol. 2007 Oct; 3(5):521-37. PMID: 17927518.
      View in: PubMed
    374. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 2007 Oct 02; 104(40):15805-10. PMID: 17890317.
      View in: PubMed
    375. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Ménard S, Croce CM. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007 Sep 15; 67(18):8699-707. PMID: 17875710.
      View in: PubMed
    376. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu X, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CM. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007 Sep; 12(3):215-29. PMID: 17785203.
      View in: PubMed
    377. Calin GA, Pekarsky Y, Croce CM. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol. 2007 Sep; 20(3):425-37. PMID: 17707831.
      View in: PubMed
    378. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007 Sep-Oct; 25(5):387-92. PMID: 17826655.
      View in: PubMed
    379. Lanza G, Ferracin M, Gafà R, Veronese A, Spizzo R, Pichiorri F, Liu CG, Calin GA, Croce CM, Negrini M. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer. 2007 Aug 23; 6:54. PMID: 17716371.
      View in: PubMed
    380. Yendamuri S, Trapasso F, Ferracin M, Cesari R, Sevignani C, Shimizu M, Rattan S, Kuroki T, Dumon KR, Bullrich F, Liu CG, Negrini M, Williams NN, Kaiser LR, Croce CM, Calin GA. Tumor suppressor functions of ARLTS1 in lung cancers. Cancer Res. 2007 Aug 15; 67(16):7738-45. PMID: 17699778.
      View in: PubMed
    381. Calin GA, Croce CM. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest. 2007 Aug; 117(8):2059-66. PMID: 17671640.
      View in: PubMed
    382. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007 Jul 01; 67(13):6092-9. PMID: 17616664.
      View in: PubMed
    383. Fabbri M, Ivan M, Cimmino A, Negrini M, Calin GA. Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther. 2007 Jul; 7(7):1009-19. PMID: 17665990.
      View in: PubMed
    384. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco A. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007 Nov 29; 26(54):7590-5. PMID: 17563749.
      View in: PubMed
    385. Kulshreshtha R, Ferracin M, Negrini M, Calin GA, Davuluri RV, Ivan M. Regulation of microRNA expression: the hypoxic component. Cell Cycle. 2007 Jun 15; 6(12):1426-31. PMID: 17582223.
      View in: PubMed
    386. Sever NI, Younan S, E Wojcik S, Spizzo R, Fabbri M, Calin GA. Use of miRNA expression profiling to identify novel biomarkers. Per Med. 2007 May; 4(2):147-155. PMID: 29788626.
      View in: PubMed
    387. Sevignani C, Calin GA, Nnadi SC, Shimizu M, Davuluri RV, Hyslop T, Demant P, Croce CM, Siracusa LD. MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A. 2007 May 08; 104(19):8017-22. PMID: 17470785.
      View in: PubMed
    388. Georgantas RW, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM, Civin CI. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A. 2007 Feb 20; 104(8):2750-5. PMID: 17293455.
      View in: PubMed
    389. Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM, Degli Uberti EC. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol. 2007 Feb; 210(2):370-7. PMID: 17111382.
      View in: PubMed
    390. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, Wang H, Sun H, Volinia S, Alder H, Calin GA, Liu CG, Andreeff M, Croce CM. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene. 2007 Jun 14; 26(28):4148-57. PMID: 17260024.
      View in: PubMed
    391. Calin GA, Croce CM. Investigation of microRNA alterations in leukemias and lymphomas. Methods Enzymol. 2007; 427:193-213. PMID: 17720486.
      View in: PubMed
    392. Georgescu EF, Stanescu L, Georgescu AC, Dumitrescu D, Foarfa C, Calin G. Bone abnormalities occurring in the follow-up of the patients with neurofibromatosis type 1. Rom J Morphol Embryol. 2007; 48(3):249-56. PMID: 17914491.
      View in: PubMed
    393. Stanescu L, Georgescu CV, Georgescu AC, Georgescu I, Calin G. Erythrokeratodermia variabilis - variant with circumscribed variable erythema and periorificial fixed Bazex Dupré erythema. Rom J Morphol Embryol. 2007; 48(4):443-7. PMID: 18060199.
      View in: PubMed
    394. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan M. A microRNA signature of hypoxia. Mol Cell Biol. 2007 Mar; 27(5):1859-67. PMID: 17194750.
      View in: PubMed
    395. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG, Rassenti L, Calin GA, Hagan JP, Kipps T, Croce CM. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 2006 Dec 15; 66(24):11590-3. PMID: 17178851.
      View in: PubMed
    396. Petrocca F, Iliopoulos D, Qin HR, Nicoloso MS, Yendamuri S, Wojcik SE, Shimizu M, Di Leva G, Vecchione A, Trapasso F, Godwin AK, Negrini M, Calin GA, Croce CM. Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer. Cancer Res. 2006 Nov 01; 66(21):10287-91. PMID: 17079447.
      View in: PubMed
    397. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006 Nov; 6(11):857-66. PMID: 17060945.
      View in: PubMed
    398. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends Mol Med. 2006 Dec; 12(12):580-7. PMID: 17071139.
      View in: PubMed
    399. Calin GA, Croce CM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene. 2006 Oct 09; 25(46):6202-10. PMID: 17028600.
      View in: PubMed
    400. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CM. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol. 2006 Oct 10; 24(29):4677-84. PMID: 16966691.
      View in: PubMed
    401. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006 Aug 01; 66(15):7390-4. PMID: 16885332.
      View in: PubMed
    402. Di Leva G, Calin GA, Croce CM. MicroRNAs: fundamental facts and involvement in human diseases. Birth Defects Res C Embryo Today. 2006 Jun; 78(2):180-9. PMID: 16847883.
      View in: PubMed
    403. Shi B, Prisco M, Calin G, Liu CG, Russo G, Giordano A, Baserga R. Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells. J Cell Physiol. 2006 Jun; 207(3):706-10. PMID: 16482530.
      View in: PubMed
    404. Calin GA, Croce CM. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Semin Oncol. 2006 Apr; 33(2):167-73. PMID: 16616063.
      View in: PubMed
    405. Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R, Volinia S, Bhatt D, Alder H, Marcucci G, Calin GA, Liu CG, Bloomfield CD, Andreeff M, Croce CM. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A. 2006 Mar 28; 103(13):5078-83. PMID: 16549775.
      View in: PubMed
    406. Sevignani C, Calin GA, Siracusa LD, Croce CM. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome. 2006 Mar; 17(3):189-202. PMID: 16518686.
      View in: PubMed
    407. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006 Mar; 9(3):189-98. PMID: 16530703.
      View in: PubMed
    408. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006 Feb 14; 103(7):2257-61. PMID: 16461460.
      View in: PubMed
    409. Zanesi N, Aqeilan R, Drusco A, Kaou M, Sevignani C, Costinean S, Bortesi L, La Rocca G, Koldovsky P, Volinia S, Mancini R, Calin G, Scott CP, Pekarsky Y, Croce CM. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice. Cancer Res. 2006 Jan 15; 66(2):915-20. PMID: 16424025.
      View in: PubMed
    410. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005 Dec 27; 102(52):19075-80. PMID: 16365291.
      View in: PubMed
    411. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, Valtieri M, Calin GA, Liu CG, Sorrentino A, Croce CM, Peschle C. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A. 2005 Dec 13; 102(50):18081-6. PMID: 16330772.
      View in: PubMed
    412. Calin GA, Garzon R, Cimmino A, Fabbri M, Croce CM. MicroRNAs and leukemias: how strong is the connection? Leuk Res. 2006 Jun; 30(6):653-5. PMID: 16330098.
      View in: PubMed
    413. Michaille JJ, Tili E, Calin GA, Garin J, Louwagie M, Croce CM. Cloning and characterization of cDNAs expressed during chick development and encoding different isoforms of a putative zinc finger transcriptional regulator. Biochimie. 2005 Nov; 87(11):939-49. PMID: 16023281.
      View in: PubMed
    414. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005 Oct 27; 353(17):1793-801. PMID: 16251535.
      View in: PubMed
    415. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005 Sep 27; 102(39):13944-9. PMID: 16166262.
      View in: PubMed
    416. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005 Aug 15; 65(16):7065-70. PMID: 16103053.
      View in: PubMed
    417. Zanesi N, Mancini R, Sevignani C, Vecchione A, Kaou M, Valtieri M, Calin GA, Pekarsky Y, Gnarra JR, Croce CM, Huebner K. Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency. Cancer Res. 2005 Aug 01; 65(15):6576-82. PMID: 16061637.
      View in: PubMed
    418. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell. 2005 Jul 15; 122(1):6-7. PMID: 16009126.
      View in: PubMed
    419. Calin GA, Trapasso F, Shimizu M, Dumitru CD, Yendamuri S, Godwin AK, Ferracin M, Bernardi G, Chatterjee D, Baldassarre G, Rattan S, Alder H, Mabuchi H, Shiraishi T, Hansen LL, Overgaard J, Herlea V, Mauro FR, Dighiero G, Movsas B, Rassenti L, Kipps T, Baffa R, Fusco A, Mori M, Russo G, Liu CG, Neuberg D, Bullrich F, Negrini M, Croce CM. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med. 2005 Apr 21; 352(16):1667-76. PMID: 15843669.
      View in: PubMed
    420. Sarti M, Sevignani C, Calin GA, Aqeilan R, Shimizu M, Pentimalli F, Picchio MC, Godwin A, Rosenberg A, Drusco A, Negrini M, Croce CM. Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):806-13. PMID: 15701871.
      View in: PubMed
    421. Pekarsky Y, Calin GA, Aqeilan R. Chronic lymphocytic leukemia: molecular genetics and animal models. Curr Top Microbiol Immunol. 2005; 294:51-70. PMID: 16323427.
      View in: PubMed
    422. Miotto E, Sabbioni S, Veronese A, Calin GA, Gullini S, Liboni A, Gramantieri L, Bolondi L, Ferrazzi E, Gafà R, Lanza G, Negrini M. Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Cancer Res. 2004 Nov 15; 64(22):8156-9. PMID: 15548679.
      View in: PubMed
    423. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A. 2004 Aug 10; 101(32):11755-60. PMID: 15284443.
      View in: PubMed
    424. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A. 2004 Jun 29; 101(26):9740-4. PMID: 15210942.
      View in: PubMed
    425. Prisco M, Maiorana A, Guerzoni C, Calin G, Calabretta B, Voit R, Grummt I, Baserga R. Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells. Mol Cell Biol. 2004 Jun; 24(12):5421-33. PMID: 15169904.
      View in: PubMed
    426. Picchio MC, Martin ES, Cesari R, Calin GA, Yendamuri S, Kuroki T, Pentimalli F, Sarti M, Yoder K, Kaiser LR, Fishel R, Croce CM. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res. 2004 Apr 15; 10(8):2720-4. PMID: 15102676.
      View in: PubMed
    427. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004 Mar 02; 101(9):2999-3004. PMID: 14973191.
      View in: PubMed
    428. Thakur S, Nakamura T, Calin G, Russo A, Tamburrino JF, Shimizu M, Baldassarre G, Battista S, Fusco A, Wassell RP, Dubois G, Alder H, Croce CM. Regulation of BRCA1 transcription by specific single-stranded DNA binding factors. Mol Cell Biol. 2003 Jun; 23(11):3774-87. PMID: 12748281.
      View in: PubMed
    429. Calin GA, Calin S, Ionescu R, Croitoru M, Diculescu M, Oproiu A. Successful local fibrinolytic treatment and balloon angioplasty in superior mesenteric arterial embolism: a case report and literature review. Hepatogastroenterology. 2003 May-Jun; 50(51):732-4. PMID: 12828073.
      View in: PubMed
    430. Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Masciullo V, D'Andrilli G, Scambia G, Picchio MC, Alder H, Godwin AK, Croce CM. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A. 2003 05 13; 100(10):5956-61. PMID: 12719539.
      View in: PubMed
    431. Sevignani C, Calin GA, Cesari R, Sarti M, Ishii H, Yendamuri S, Vecchione A, Trapasso F, Croce CM. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res. 2003 Mar 15; 63(6):1183-7. PMID: 12649173.
      View in: PubMed
    432. Calin GA, Vasilescu C, Negrini M, Barbanti-Brodano G. Genetic chaos and antichaos in human cancers. Med Hypotheses. 2003 Feb; 60(2):258-62. PMID: 12606244.
      View in: PubMed
    433. Sabbioni S, Miotto E, Veronese A, Sattin E, Gramantieri L, Bolondi L, Calin GA, Gafà R, Lanza G, Carli G, Ferrazzi E, Feo C, Liboni A, Gullini S, Negrini M. Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. Mol Diagn. 2003; 7(3-4):201-7. PMID: 15068392.
      View in: PubMed
    434. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002 Nov 26; 99(24):15524-9. PMID: 12434020.
      View in: PubMed
    435. Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R, Russo G, Hardy RR, Croce CM. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A. 2002 May 14; 99(10):6955-60. PMID: 12011454.
      View in: PubMed
    436. Scelfo RA, Schwienbacher C, Veronese A, Gramantieri L, Bolondi L, Querzoli P, Nenci I, Calin GA, Angioni A, Barbanti-Brodano G, Negrini M. Loss of methylation at chromosome 11p15.5 is common in human adult tumors. Oncogene. 2002 Apr 11; 21(16):2564-72. PMID: 11971191.
      View in: PubMed
    437. Bullrich F, Fujii H, Calin G, Mabuchi H, Negrini M, Pekarsky Y, Rassenti L, Alder H, Reed JC, Keating MJ, Kipps TJ, Croce CM. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res. 2001 Sep 15; 61(18):6640-8. PMID: 11559527.
      View in: PubMed
    438. Calin G, Ranzani GN, Amadori D, Herlea V, Matei I, Barbanti-Brodano G, Negrini M. Somatic frameshift mutations in the Bloom syndrome BLM gene are frequent in sporadic gastric carcinomas with microsatellite mutator phenotype. BMC Genet. 2001; 2:14. PMID: 11532193.
      View in: PubMed
    439. Mabuchi H, Fujii H, Calin G, Alder H, Negrini M, Rassenti L, Kipps TJ, Bullrich F, Croce CM. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. Cancer Res. 2001 Apr 01; 61(7):2870-7. PMID: 11306461.
      View in: PubMed
    440. Calin GA, Gafà R, Tibiletti MG, Herlea V, Becheanu G, Cavazzini L, Barbanti-Brodano G, Nenci I, Negrini M, Lanza G. Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int J Cancer. 2000 May 20; 89(3):230-5. PMID: 10861498.
      View in: PubMed
    441. Schwienbacher C, Gramantieri L, Scelfo R, Veronese A, Calin GA, Bolondi L, Croce CM, Barbanti-Brodano G, Negrini M. Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. Proc Natl Acad Sci U S A. 2000 May 09; 97(10):5445-9. PMID: 10779553.
      View in: PubMed
    442. Schwienbacher C, Angioni A, Scelfo R, Veronese A, Calin GA, Massazza G, Hatada I, Barbanti-Brodano G, Negrini M. Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor. Cancer Res. 2000 Mar 15; 60(6):1521-5. PMID: 10749116.
      View in: PubMed
    443. Calin GA, di Iasio MG, Caprini E, Vorechovsky I, Natali PG, Sozzi G, Croce CM, Barbanti-Brodano G, Russo G, Negrini M. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene. 2000 Feb 24; 19(9):1191-5. PMID: 10713707.
      View in: PubMed
    444. Wilkinson ML, Hodgson SH. FAP and marfanoid habitus. Eur J Hum Genet. 2000 Feb; 8(2):153. PMID: 10757650.
      View in: PubMed
    445. Calin G, Ivan M, Stefanescu D. The difference between p53 mutation frequency in haematological and non-haematological malignancies: possible explanations. Med Hypotheses. 1999 Oct; 53(4):326-8. PMID: 10608267.
      View in: PubMed
    446. Calin G, Wijnen J, van der Klift H, Ionita A, Mulder A, Breukel C, Smits R, Dauwerse H, Hansson K, Calin S, Stefanescu D, Oproiu A, Fodde R. Marfan-like habitus and familial adenomatous polyposis in two unrelated males: a significant association? Eur J Hum Genet. 1999 Jul; 7(5):609-14. PMID: 10439970.
      View in: PubMed
    447. di Iasio MG, Calin G, Tibiletti MG, Vorechovsky I, Benediktsson KP, Taramelli R, Barbanti-Brodano G, Negrini M. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region. Oncogene. 1999 Feb 25; 18(8):1635-8. PMID: 10102634.
      View in: PubMed
    448. Calin G, Herlea V, Barbanti-Brodano G, Negrini M. The coding region of the Bloom syndrome BLM gene and of the CBL proto-oncogene is mutated in genetically unstable sporadic gastrointestinal tumors. Cancer Res. 1998 Sep 01; 58(17):3777-81. PMID: 9731483.
      View in: PubMed
    449. Mircioiu C, Perju A, Neagu A, Griu E, Calin G, Miron DS. Pharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administration. Eur J Drug Metab Pharmacokinet. 1998 Jul-Sep; 23(3):391-6. PMID: 9842982.
      View in: PubMed
    450. Mircioiu C, Perju A, Griu E, Calin G, Neagu A, Enachescu D, Miron DS. Pharmacokinetics of progesterone in postmenopausal women: 2. Pharmacokinetics following percutaneous administration. Eur J Drug Metab Pharmacokinet. 1998 Jul-Sep; 23(3):397-402. PMID: 9842983.
      View in: PubMed
    451. Maximilian C, Stefanescu D, Calin G. Genetic services in Romania. Eur J Hum Genet. 1997; 5 Suppl 2:145-7. PMID: 9450213.
      View in: PubMed
    452. Calin G, Stefanescu D. Can the loss of negative regulation theory be compatible with the development of hematological malignancies - (review). Oncol Rep. 1995 Sep; 2(5):875-8. PMID: 21597834.
      View in: PubMed
    453. Calin G. Oncogenes and tumor-suppressor genes - 2 different looks of the same gene. Oncol Rep. 1994 Sep; 1(5):987-91. PMID: 21607481.
      View in: PubMed
    454. Stefanescu DT, Colita D, Nicoara S, Calin G. t(1;7)(p36;q32): a new recurring abnormality in primary myelodysplastic syndrome. Cancer Genet Cytogenet. 1994 Jul 15; 75(2):103-5. PMID: 8055471.
      View in: PubMed
    455. Stefanescu D, Colita D, Calin G. A complex translocation t(1-12-11) in a patient with hodgkins-disease. Oncol Rep. 1994 Jul; 1(4):837-9. PMID: 21607451.
      View in: PubMed
    456. Stefanescu DT, Colita D, Motoiu I, Calin G. T-cell malignant lymphoma with a complex unbalanced translocation (8;11;14). Cancer Genet Cytogenet. 1993 Oct 01; 70(1):71-3. PMID: 8221616.
      View in: PubMed
    457. Calin G. Oncogenes and tumor suppressor genes--two different looks of the same gene? Roum Arch Microbiol Immunol. 1992 Oct-Dec; 51(4):271-3. PMID: 1304831.
      View in: PubMed
    458. Proca E, Calin G. [Medical treatment of complete urinary retention with alpha blockaders]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1983 May-Jun; 32(3):161-8. PMID: 6151721.
      View in: PubMed
    459. Proca E, Calin C, Calin G, Gurtavenco A. [Bacteriological study of patients treated with urethro-vesical catheterization]. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1982 Apr-Jun; 27(2):73-80. PMID: 7146760.
      View in: PubMed
    460. Proca E, Calin G, Popescu A. [Glenn-Cohen-Anderson operation in the treatment of vesico-renal reflux]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1980 May-Jun; 29(3):183-91. PMID: 6450968.
      View in: PubMed
    461. Calin G. [Atypical characteristics of present-day osteoarticular tuberculosis]. Ftiziologia. 1972 Mar-Apr; 21(2):167-76. PMID: 5055735.
      View in: PubMed
    462. Calin G. [Value and role of cyto-histo-bacteriological studies in making the diagnosis of the nature and stage of extrarespiratory tuberculosis]. Ftiziologia. 1972 Jan-Feb; 21(1):59-66. PMID: 4578083.
      View in: PubMed
    463. Calin G, Macovei D, Teodoru A. [Progesterone deficiency in cervical isthmic incompetence]. Rev Med Chir Soc Med Nat Iasi. 1971 Oct-Dec; 75(4):933-8. PMID: 5164534.
      View in: PubMed
    464. Calin G. Intraabdominal tuberculosis--surgical findings. Rom Med Rev. 1969; 13(4):62-9. PMID: 5364540.
      View in: PubMed
    465. Olanescu G, Popescu E, Ivanovici F, Calin G. [Colocystoplasty for enlargement of urine capacity of the bladder. Indications and results]. Urologe. 1967 May-Jun; 6(3):145-53. PMID: 5589311.
      View in: PubMed
    466. GAVRILESCU C, CALIN G, ALTARESCU M, NADOLU G, ZAMFIR M. [GENITAL HEMATOMA, A GRAVE APOPLECTIC DISORDER OF LATE PREGNANCY TOXEMIA]. Rev Med Chir Soc Med Nat Iasi. 1964 Apr-Jun; 68:375-9. PMID: 14301261.
      View in: PubMed
    467. HAIMOVICI-HANES N, CALIN G. [The education, re-education and readaption to work, during hospitalization, of extra-pulmonary tuberculotics]. Arch Mal Prof. 1959 Sep-Oct; 20:548-51. PMID: 14398881.
      View in: PubMed
    468. Targeting IL11 receptor in leukemia and lymphoma. Clinical Cancer Research. 21:3041-3051.
    469. From cell biology to immunology. OncoImmunology. 5.
    470. Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes. Modern Pathology.
    471. High throughput microRNAs profiling in cancers. 309-321.
    472. Circulating free xeno-microRNAs - The new kids on the block. Molecular Oncology. 10:503-508.
    473. The ZNF304-integrin axis protects against anoikis in cancer. Nature Communications. 6.
    474. SnapShot. Cell Metabolism. 25:220-220.e1.
    475. An integrative analysis to identify driver genes in esophageal squamous cell carcinoma. PLoS One. 10.
    476. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene.
    477. Current status of long non-coding RNAs in human breast cancer. International Journal of Molecular Sciences. 17.
    478. VEGFR-1 pseudogene expression and regulatory function in human colorectal cancer cells. Molecular Cancer Research. 13:1274-1282.
    479. In vivo delivery of miR-34a sensitizes lung tumors to radiation through RAD51 regulation. Molecular Therapy - Nucleic Acids. 4.
    480. Cellular and viral microRNAs in sepsis. Cell Death and Differentiation.
    481. Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways. Minerva Biotecnologica. 20:13-21.
    482. Profiling long noncoding RNA expression using custom-designed microarray. 33-41.
    483. Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma. Oncotarget. 7:31361-31371.
    484. In silico prediction of target SNPs affecting miR-mRNA interaction. 211-214.
    485. Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer. Cell Reports. 15:1493-1504.
    486. Oncogenes and tumor suppressor genes - two different looks of the same gene?. Oncology Reports. 1:987-991.
    487. Correction to Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2 [Molecular Cell 61, 520-534, (2016)]. Molecular Cell. 61:640.
    488. MicroRNAs and drug resistance. 257-270.
    489. Targeting microRNAs as key modulators of tumor immune response. Journal of Experimental and Clinical Cancer Research. 35.
    490. The authors reply [3]. New England Journal of Medicine. 354:525.
    491. Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis. Oncotarget. 7:20636-20654.
    492. MicroRNAs. Clinical Leukemia. 3:20-32.
    493. MicroRNAs as Drugs and Drug Targets in Cancer. 97-111.
    494. Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway. Oncogene.
    495. Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. Cell Reports. 13:2395-2402.
    496. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. Oncotarget. 6:37269-37280.
    497. Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. Oncotarget. 7:53165-53177.
    498. Beyond Mirnas. 247-264.
    499. EBioMedicine. 12:34-42.
    500. Erratum. Nature Genetics. 42:464.
    501. Examining plasma microRNA markers for colorectal cancer at different stages. Oncotarget. 7:11434-11449.
    502. H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer. EBioMedicine. 13:113-124.
    503. From the biology of PP2A to the PADs for therapy of hematologic malignancies. Frontiers in Oncology. 4 AUG.
    504. Hodgkin Lymphoma Cells Have a Specific Long Noncoding RNA Expression Pattern. American Journal of Pathology. 186:2251-2253.
    505. Clinically relevant microRNAs in ovarian cancer. Molecular Cancer Research. 13:393-401.
    506. Can the loss of negative regulation theory be compatible with the development of hematological malignancies?. Oncology Reports. 2:875-878.
    507. MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. Oncotarget. 7:49217-49231.
    508. Long non-coding RNAs in primary myelofibrosis. Leukemia and Lymphoma. 56:281-282.
    509. From mobility to crosstalk. A model of intracellular miRNAs motion may explain the RNAs interaction mechanism on the basis of target subcellular localization. Mathematical Biosciences. 280:50-61.
    510. The Role of MicroRNAs and Ultraconserved Non-Coding RNAs in Cancer. 435-447.
    511. A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. Genome Medicine. 6.
    512. Ofatumumab and lenalidomide for patients with relapsed or refractory chronic lymphocytic leukemia. Clinical Cancer Research. 22:2359-2367.
    513. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs. Proceedings of the National Academy of Sciences of the United States of America. 112:E1106-E1115.
    514. Bioinformatics, non-coding RNAs and its possible application in personalized medicine. 21-37.
    515. The authors reply [12]. New England Journal of Medicine. 354:1205.
    516. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut.
    517. Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells. Cancer Research. 76:7194-7207.
    518. MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer. Oncogene.
    519. Drug-MicroRNA Cross-Talk. 991-1016.
    520. Erratum. Nature Genetics. 48:221.
    521. Non-coding RNAs and cancer. Journal of Nucleic Acids Investigation. 2:27-30.
    522. Erratum. Journal of Cellular Biochemistry. 115:2045.
    523. Principles of MicroRNA involvement in breast cancer. Breast Diseases. 22:238-243.
    524. MALAT1 promoted invasiveness of gastric adenocarcinoma. BMC Cancer. 17.
    525. MiRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discovery. 6:235-246.
    526. Familial cancer and ARLTS1 [1] (multiple letters). New England Journal of Medicine. 353:313-314.
    527. MicroRNAs in cancer (an overview). 1-71.
    528. Identification of circulating MicroRNA signatures for breast cancer detection. Breast Diseases. 25:31-33.
    529. When kissing (disease) counts. Blood. 127:1947-1948.
    530. MicroRNAs and other non-coding RNAs. 1-12.
    531. Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression. Cancer Cell. 29:607-608.
    532. Describing a transcription factor dependent regulation of the micro RNA transcriptome. Journal of Visualized Experiments. 2016.
    533. MicroRNA involvement in intestinal tumorigenesis. 169-188.
    534. Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer. Clinical Cancer Research. 21:2127-2137.
    535. MicroRNAs in mouse models of lymphoid malignancies. Journal of Nucleic Acids Investigation. 1:36-40.
    536. Soy isoflavone genistein-mediated downregulation of miR-155 contributes to the anticancer effects of genistein. Nutrition and Cancer. 68:154-164.
    537. RNA as a Therapeutic Molecule.
    538. Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi. Blood Cells, Molecules, and Diseases. 55:420.
    539. Micrornas and cancer therapeutics. 637-645.
    540. Breast Diseases. 27:44-45.
    541. MicroRNAs in myeloid hematological malignancies. Current Genomics. 16:336-348.
    542. Design of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma. Molecular and Cellular Probes.
    543. Human cancers. Journal of Translational Medicine and Research. 21:168-172.
    544. Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. OncoImmunology.
    545. The emerging role of long noncoding RNAs in oral cancer. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 123:235-241.
    546. The clinical relevance of long non-coding RNAs in cancer. Cancers. 7:2169-2182.
    547. Use of miRNA expression profiling to identify novel biomarkers. Personalized Medicine. 4:147-155.
    548. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs. Oncotarget. 6:7262-7279.
    549. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro-Oncology. 18:639-648.
    550. Patients after splenectomy. Chirurgia (Romania). 111:393-399.
    551. The miR-143/miR-145 cluster and the tumor microenvironment. Genome Medicine. 8.
    552. Involvement of MicroRNAs in human cancer. 69-104.
    553. Bigger data is better for molecular diagnosis tests based on decision trees. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 9714:288-295.
    554. From the biology of PP2A to the PADs for therapy of hematologic malignancies. Frontiers in Oncology. 5.
    555. Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine.
    556. PD-L1 expression and prognostic impact in glioblastoma. Neuro-Oncology. 18:195-205.
    557. miR-141-mediated regulation of brain metastasis from breast cancer. Journal of the National Cancer Institute. 108.
    558. Erratum. Proceedings of the National Academy of Sciences of the United States of America. 103:2464.
    559. Small silencing non-coding RNAs. 481-496.
    560. Micrornas as therapeutic targets. 683-697.
    561. Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. Oncogene.
    562. Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotarget. 7:15093-15104.
    563. In response [2]. Cancer Research. 67:4534.
    564. Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases. Genes Chromosomes and Cancer. 55:193-214.
    565. Progresses towards safe and efficient gene therapy vectors. Oncotarget. 6:30675-30703.
    566. Low spinophilin expression enhances aggressive biological behavior of breast cancer. Oncotarget. 6:11191-11202.
    567. The Potential of MicroRNAs as Prostate Cancer Biomarkers. European Urology.
    568. RNA as a Therapeutic Molecule. 691-699.
    CALIN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description